Overview, Makes use of, Aspect Results, Precautions, Interactions, Dosing and Opinions

Abbasi, S. H., Heidari, S., Mohammadi, M. R., Tabrizi, M., Ghaleiha, A., and Akhondzadeh, S. Acetyl-L-carnitine as an adjunctive remedy within the remedy of attention-deficit/hyperactivity dysfunction in youngsters and adolescents: a placebo-controlled trial. Little one Psychiatry Hum.Dev. 2011;42(3):367-375. View summary.

Abbott CA, Vileikyte L, Williamson S, and et al. Impact of remedy with acetyl-l-carnitine on diabetic foot ulceration in sufferers with peripheral neuropathy: a 1 12 months potential multi-centre research. Diabetologia 1997;40:A556.

Abd-Allah, A. R., Helal, G. Okay., Al-Yahya, A. A., Aleisa, A. M., Al-Rejaie, S. S., and Al-Bakheet, S. A. Professional-inflammatory and oxidative stress pathways which compromise sperm motility and survival could also be altered by L-carnitine. Oxid.Med.Cell Longev. 2009;2(2):73-81. View summary.

Abdel-Azid MT, Abdou MS, Soliman Okay, and et al. Impact of carnitine on blood lipid sample in diabetic sufferers. Nutr Rep Internat 1984;29:1071-1079.

Ahmet, U., Abdurrahman, Okay., Sait, B., Ahmet, E., Salih, D., Mendane, S., Ates, Y., Fatih, B., Necmettin, Okay., and Kemal, D. L-carnitine remedy in non-alcoholic steatohepatitis. Turk.J Pediatr. 2000;11(3):196-201.

Al’miasheva, M. I., Balashov, V. P., Ivianskii, S. A., Markelova, I. A., Kul’kova, N. P., and Balykova, L. A. [Experimental study of the effects of metabolic drugs on exercise tolerance]. Vopr.Kurortol.Fizioter.Lech.Fiz Kult. 2007;(4):15-17. View summary.

Al-Sannaa, N. A. and Cheriyan, G. M. Carnitine-acylcarnitine translocase deficiency. Medical course of three Saudi youngsters with a extreme phenotype. Saudi.Med.J 2010;31(8):931-934. View summary.

Aledo, R., Mir, C., Dalton, R. N., Turner, C., Pie, J., Hegardt, F. G., Casals, N., and Champion, M. P. Refining the analysis of mitochondrial HMG-CoA synthase deficiency. J Inherit.Metab Dis 2006;29(1):207-211. View summary.

Allegra, C., Antignani, P. L., Schachter, I., Koverech, A., Messano, M., and Virmani, A. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive illness. Ann.Vasc.Surg. 2008;22(4):552-558. View summary.

Altmann P, Thompson C Graham Okay Ringrose T Taylor D Types P Radda G. Randomized placebo managed research on intravenous L-carnitine supplementation in hemodialysis patients-No profit in vivo magnetic resonance spectroscopic evaluation of muscle [abstract]. 1999;

Altunbasak, S., Baytok, V., Tasouji, M., Herguner, O., Burgut, R., and Kayrin, L. Asymptomatic hyperammonemia in youngsters handled with valproic acid. J Little one Neurol. 1997;12(7):461-463. View summary.

Alvarez, T. M., Guardiola, P. D., Roldan, J. O., Elviro, R., Wevers, R., and Guijarro, G. [Primary trimethylaminuria: the fish odor syndrome]. Endocrinol.Nutr. 2009;56(6):337-340. View summary.

Amadeo A, Bonollo L, Botto G, and et al. [Evaluation of efficacy of propionyl-L-carnitine in chronic oral administration on cardiac muscle efficiency, on tolerance to exercise and on life quality of patients with chronic cardiac failure. Double blind comparison with L-carnitine and placebo]. Rass Int Clin Ter 1992;72(3):117-131.

Amen, D. G., Wu, J. C., Taylor, D., and Willeumier, Okay. Reversing mind injury in former NFL gamers: implications for traumatic mind damage and substance abuse rehabilitation. J Psychoactive Medicine 2011;43(1):1-5. View summary.

Amin, Okay. A. and Nagy, M. A. Impact of Carnitine and natural combination extract on weight problems induced by excessive fats food plan in rats. Diabetol.Metab Syndr. 2009;1(1):17. View summary.

Andreozzi, G. M., Leone, A., Laudani, R., Martin, R., Deinit, G., and Cataldi, V. Levo-propionyl-carnitine improves the effectiveness of supervised bodily coaching on absolutely the claudication distance in sufferers with intermittent claudication. Angiology 2008;59(1):84-89. View summary.

Angelini, C., Federico, A., Reichmann, H., Lombes, A., Chinnery, P., and Turnbull, D. Activity power pointers handbook: EFNS pointers on analysis and administration of fatty acid mitochondrial issues. Eur.J Neurol. 2006;13(9):923-929. View summary.

Annadurai, T., Vigneshwari, S., Thirukumaran, R., Thomas, P. A., and Geraldine, P. Acetyl-L-carnitine prevents carbon tetrachloride-induced oxidative stress in numerous tissues of Wistar rats. J Physiol Biochem. 2011;67(4):519-530. View summary.

Nameless. Examine on propionyl-L-carnitine in power coronary heart failure. Eur Coronary heart J 1999;20(1):70-76. View summary.

Arbeiter, A. Okay., Kranz, B., Wingen, A. M., Bonzel, Okay. E., Dohna-Schwake, C., Hanssler, L., Neudorf, U., Hoyer, P. F., and Buscher, R. Steady venovenous haemodialysis (CVVHD) and steady peritoneal dialysis (CPD) within the acute administration of 21 youngsters with inborn errors of metabolism. Nephrol.Dial Transplant 2010;25(4):1257-1265. View summary.

Ardissone P, Baccolla D, Barberis L, and et al. The consequences of remedy with L-carnitine of hypoglycemia in preterm AGA infants. Curr Ther Res 1985;38:256-264.

Arduini, A., Bonomini, M., Clutterbuck, E. J., Laffan, M. A., and Pusey, C. D. Impact of L-carnitine administration on erythrocyte survival in haemodialysis sufferers. Nephrol.Dial Transplant 2006;21(9):2671-2672. View summary.

Arenas, J., Ricoy, J. R., Encinas, A. R., Pola, P., D’Iddio, S., Zeviani, M., Didonato, S., and Corsi, M. Carnitine in muscle, serum, and urine of nonprofessional athletes: results of bodily train, coaching, and L-carnitine administration. Muscle Nerve 1991;14(7):598-604. View summary.

Arnold, L. E., Amato, A., Bozzolo, H., Hollway, J., Cook dinner, A., Ramadan, Y., Crowl, L., Zhang, D., Thompson, S., Testa, G., Kliewer, V., Wigal, T., McBurnett, Okay., and Manos, M. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity dysfunction: a multi-site, placebo-controlled pilot trial. J Little one Adolesc.Psychopharmacol. 2007;17(6):791-802. View summary.

Arockia Rani, P. J. and Panneerselvam, C. Carnitine as a free radical scavenger in getting older. Exp Gerontol. 2001;36(10):1713-1726. View summary.

Arrigo, A., Casale, R., Buonocore, M., and Ciano, C. Results of acetyl-L-carnitine on response occasions in sufferers with cerebrovascular insufficiency. Int J Clin Pharmacol Res 1990;10(1-2):133-137. View summary.

Asilsoy, S., Bekem, O., Karaman, O., Uzuner, N., and Kavukcu, S. Serum whole and free carnitine ranges in youngsters with bronchial asthma. World J Pediatr. 2009;5(1):60-62. View summary.

Augustyniak, A., Stankiewicz, A., and Skrzydlewska, E. The Affect of L-Carnitine on Oxidative Modification of LDL In Vitro. Toxicol.Mech.Strategies 2008;18(6):455-462. View summary.

Auinger, Okay., Muller, V., Rudiger, A., and Maggiorini, M. Valproic acid intoxication imitating mind demise. Am.J Emerg.Med. 2009;27(9):1177-6. View summary.

Azevedo, O., Vilarinho, L., Almeida, F., Ferreira, F., Guardado, J., Ferreira, M., Lourenco, A., Medeiros, R., and Almeida, J. Cardiomyopathy and kidney illness in a affected person with maternally inherited diabetes and deafness attributable to the 3243A>G mutation of mitochondrial DNA. Cardiology 2010;115(1):71-74. View summary.

Azumano, I. and Yamanishi, T. A brand new use of pantothenic acid in metabolic syndrome remedy. Kagaku to Seibutsu 2008;46(6):400-404.

Bain, M. A., Faull, R., Milne, R. W., and Evans, A. M. Oral L-carnitine: metabolite formation and hemodialysis. Curr.Drug Metab 2006;7(7):811-816. View summary.

Bajerska, J., Jeszka, J., Czapka-Matyasik, M., and Kostrzewa-Tarnowska, A. [Does L-carnitine supplementation can improve physical performance of athletes?]. Zywienie Czowieka i Metabolizm 2009;36(1):118-123.

Baker, S. Okay. and Lipson, D. M. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia. J Pediatr.Hematol.Oncol. 2010;32(3):e114-e117. View summary.

Balasaraswathi, Okay., Rajasekar, P., and Anuradha, C. V. Adjustments in redox ratio and protein glycation in precataractous lens from fructose-fed rats: results of exogenous L-carnitine. Clin Exp.Pharmacol Physiol 2008;35(2):168-173. View summary.

Balercia, G., Regoli, F., Armeni, T., Koverech, A., Mantero, F., and Boscaro, M. Placebo-controlled double-blind randomized trial on using L-carnitine, L-acetylcarnitine, or mixed L-carnitine and L-acetylcarnitine in males with idiopathic asthenozoospermia. Fertil.Steril. 2005;84(3):662-671. View summary.

Balogh, D., Hackl, J. M., Legenstein, E., and Musil, H. E. [Experiences with L-carnitine in the post-stress phase]. Infusionsther.Klin Ernahr. 1986;13(5):204-208. View summary.

Bangma, H. R., Smit, G. P., Kuks, J. B., Grevink, R. G., and Wolffenbuttel, B. H. [Two patients with mitochondrial respiratory chain disease]. Ned.Tijdschr.Geneeskd. 10-18-2008;152(42):2298-2301. View summary.

Barker, G. A., Inexperienced, S., Askew, C. D., Inexperienced, A. A., and Walker, P. J. Impact of propionyl-L-carnitine on train efficiency in peripheral arterial illness. Med Sci Sports activities Exerc. 2001;33(9):1415-1422. View summary.

Bassi S, Ferrarese C, Finoia MG, and et al. L-acetyl-carnitine in Alzheimer illness (A.D.) and senile dementia Alzheimer sort (S.D.A.T.). Senile Dementias.II Worldwide Symposium 1988;461-466.

Battistin L, Pizzolato G, Dam M, and et al. Results of acetyl-L-carnitine (ALC) remedy in dementia: A multicentric, randomized, double-blind research. New Tendencies Clin Neuropharmacol 1989;3(2):131-132.

Baudouin, C., Cochener, B., Pisella, P. J., Girard, B., Pouliquen, P., Cooper, H., and Creuzot-Garcher, C. Randomized, part III research evaluating osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye illness. Eur.J Ophthalmol. 2012;22(5):751-761. View summary.

Bavbek, N., Akay, H., Uz, B., Uz, E., Turgut, F., Kanbay, M., Senes, M., Akcay, A., and Duranay, M. The consequences of L-carnitine remedy on respiratory operate checks in power hemodialysis sufferers. Ren Fail. 2010;32(2):157-161. View summary.

Bazzato, G., Mezzina, C., Ciman, M., and Guarnieri, G. Myasthenia-like syndrome related to carnitine in sufferers on long- time period haemodialysis. Lancet 5-12-1979;1(8124):1041-1042. View summary.

Bellinghieri, G., Savica, V., Barbera, C. M., Ricciardi, B., Egitto, M., Torre, F., Valentini, G., D’Iddio, S., Bagiella, E., Mallamace, A., and . L-carnitine and platelet aggregation in uremic sufferers subjected to hemodialysis. Nephron 1990;55(1):28-32. View summary.

Bellinghieri, G., Savica, V., Mallamace, A., Di, Stefano C., Consolo, F., Spagnoli, L. G., Villaschi, S., Palmieri, G., Corsi, M., and Maccari, F. Correlation between elevated serum and tissue L-carnitine ranges and improved muscle signs in hemodialyzed sufferers. Am.J Clin Nutr. 1983;38(4):523-531. View summary.

Benedini, S., Perseghin, G., Terruzzi, I., Scifo, P., Invernizzi, P. L., Del, Maschio A., Lazzarin, A., and Luzi, L. Impact of L-acetylcarnitine on physique composition in HIV-related lipodystrophy. Horm.Metab Res. 2009;41(11):840-845. View summary.

Benton, D. and Donohoe, R. T. The affect on cognition of the interactions between lecithin, carnitine and carbohydrate. Psychopharmacology (Berl) 2004;175(1):84-91. View summary.

Bernard, A., Rigault, C., Mazue, F., Le, Borgne F., and Demarquoy, J. L-carnitine supplementation and bodily train restore age-associated decline in some mitochondrial capabilities within the rat. J Gerontol.A Biol.Sci Med.Sci 2008;63(10):1027-1033. View summary.

Bertoli, M., Battistella, P. A., Vergani, L., Naso, A., Gasparotto, M. L., Romagnoli, G. F., and Angelini, C. Carnitine deficiency induced throughout hemodialysis and hyperlipidemia: impact of alternative remedy. Am J Clin Nutr 1981;34(8):1496-1500. View summary.

Biagini, A., Opie, L., Rovai, D., Mazzei, M. G., Carpeggiani, C., and Maseri, A. Intravenous dl-carnitine fails to extend the double-product throughout atrial pacing in sufferers with effort angina. A double-blind randomized research. G Ital Cardiol 1983;13(11):291-294. View summary.

Bianchi, G., Vitali, G., Caraceni, A., Ravaglia, S., Capri, G., Cundari, S., Zanna, C., and Gianni, L. Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-l-carnitine. Eur.J Most cancers 7-19-2005; View summary.

Bijarnia, S., Wiley, V., Carpenter, Okay., Christodoulou, J., Ellaway, C. J., and Wilcken, B. Glutaric aciduria sort I: consequence following detection by new child screening. J Inherit.Metab Dis 2008;31(4):503-507. View summary.

Biolo, G., Stulle, M., Bianco, F., Mengozzi, G., Barazzoni, R., Vasile, A., Panzetta, G., and Guarnieri, G. Insulin motion on glucose and protein metabolism throughout L-carnitine supplementation in upkeep haemodialysis sufferers. Nephrol.Dial Transplant 2008;23(3):991-997. View summary.

Bjornsson, E. Hepatotoxicity related to antiepileptic medication. Acta Neurol.Scand. 2008;118(5):281-290. View summary.

Block, Okay. I., Koch, A. C., Mead, M. N., Tothy, P. Okay., Newman, R. A., and Gyllenhaal, C. Influence of antioxidant supplementation on chemotherapeutic toxicity: a scientific assessment of the proof from randomized managed trials. Int.J Most cancers 9-15-2008;123(6):1227-1239. View summary.

Bloomer, R. J., Farney, T. M., Trepanowski, J. F., McCarthy, C. G., Canale, R. E., and Schilling, B. Okay. Comparability of pre-workout nitric oxide stimulating dietary dietary supplements on skeletal muscle oxygen saturation, blood nitrate/nitrite, lipid peroxidation, and higher physique train efficiency in resistance skilled males. J Int.Soc.Sports activities Nutr. 2010;7:16. View summary.

Bloomer, R. J., Tschume, L. C., and Smith, W. A. Glycine propionyl-L-carnitine modulates lipid peroxidation and nitric oxide in human topics. Int.J Vitam.Nutr.Res. 2009;79(3):131-141. View summary.

Bodea, F., Bocea, A., and Decea, N. [L-carnitine decreases oxidative stress induced by experimental hypobaric hypoxia]. Pediatr.Endocrinol.Diabetes Metab 2010;16(2):78-81. View summary.

Bohles H, Noppeney T, Akcetin Z, and et al. The impact of preoperative L-carnitine supplementation on myocardial metabolism throughout aorto-coronary-bypass surgical procedure. Present Therapeutic Analysis 1986;39(3):429-435.

Bohmer, T., Boen, A., and Hoymork, S. C. Valproate-induced hyperammonemic encephalopathy, quickly improved by i.v. carnitine and glucose/thiamine. Scand.J Gastroenterol. 2010;45(6):762-763. View summary.

Bolognesi, M., Amodio, P., Merkel, C., Godi, L., and Gatta, A. Impact of 8-day remedy with propionyl-L-carnitine on muscular and subcutaneous blood circulate of the decrease limbs in sufferers with peripheral arterial illness. Clin Physiol 1995;15(5):417-423. View summary.

Bonavita E, Bertuzzi D, Bonavita J, and et al. L-acetylcarnitine (L-AC) (Branigen) in the long run symptomatic remedy of senile dementia. Clin Trials J 1988;25:227-237.

Bonavita, E. Examine of the efficacy and tolerability of L-acetylcarnitine remedy within the senile mind. Int J Clin Pharmacol.Ther Toxicol. 1986;24(9):511-516. View summary.

Boneh, A., Beauchamp, M., Humphrey, M., Watkins, J., Peters, H., and Yaplito-Lee, J. New child screening for glutaric aciduria sort I in Victoria: remedy and consequence. Mol.Genet.Metab 2008;94(3):287-291. View summary.

Bonilla, Guerrero R., Wolfe, L. A., Payne, N., Tortorelli, S., Matern, D., Rinaldo, P., Gavrilov, D., Melan, M., He, M., Steinberg, S. J., Raymond, G. V., Vockley, J., and Gibson, Okay. M. Important fatty acid profiling for routine dietary evaluation unmasks adrenoleukodystrophy in an toddler with isovaleric acidaemia. J Inherit.Metab Dis 2008;31 Suppl 2:S453-S456. View summary.

Borghi-Silva, A., Baldissera, V., Sampaio, L. M., Pires-DiLorenzo, V. A., Jamami, M., Demonte, A., Marchini, J. S., and Costa, D. L-carnitine as an ergogenic support for sufferers with power obstructive pulmonary illness submitted to whole-body and respiratory muscle coaching packages. Braz.J Med.Biol.Res. 2006;39(4):465-474. View summary.

Brass, E. P., Adler, S., Sietsema, Okay. E., Hiatt, W. R., Orlando, A. M., and Amato, A. Intravenous L-carnitine will increase plasma carnitine, reduces fatigue, and will protect train capability in hemodialysis sufferers. Am J Kidney Dis. 2001;37(5):1018-1028. View summary.

Brass, E. P., Hoppel, C. L., and Hiatt, W. R. Impact of intravenous L-carnitine on carnitine homeostasis and gasoline metabolism throughout train in people. Clin Pharmacol Ther 1994;55(6):681-692. View summary.

Brevetti G, Chiariello M, Policicchio A, and et al. L-carnitine will increase strolling distance in sufferers with peripheral artery illness. Eur Coronary heart J 1984;5(Abstr Suppl 1):138.

Brevetti, G., Attisano, T., Perna, S., Rossini, A., Policicchio, A., and Corsi, M. Impact of L-carnitine on the reactive hyperemia in sufferers affected by peripheral vascular illness: a double-blind, crossover research. Angiology 1989;40(10):857-862. View summary.

Brevetti, G., di Lisa, F., Perna, S., Menabo, R., Barbato, R., Martone, V. D., and Siliprandi, N. Carnitine-related alterations in sufferers with intermittent claudication: indication for a targeted carnitine remedy. Circulation 5-1-1996;93(9):1685-1689. View summary.

Broad, E. M., Maughan, R. J., and Galloway S DR. Results of train depth and altered substrate availability on cardiovascular and metabolic responses to train after oral carnitine supplementation in athletes. Int.J Sport Nutr.Exerc.Metab 2011;21(5):385-397. View summary.

Brunel-Guitton, C., Costa, T., Mitchell, G. A., and Lambert, M. Remedy of cobalamin C (cblC) deficiency throughout being pregnant. J Inherit.Metab Dis 9-10-2010; View summary.

Cai, H., Yi, W., Li, M., and et al. The impact of levocarnitine for plasmatic matrix metalloproteinases (MMPS) on acute cerebral infarct sufferers. Fashionable Preventive Med. 2010;37(12):2353-2354.

Cai, T., Wagenlehner, F. M., Mazzoli, S., Meacci, F., Mondaini, N., Nesi, G., Tiscione, D., Malossini, G., and Bartoletti, R. Semen high quality in sufferers with Chlamydia trachomatis genital an infection handled concurrently with prulifloxacin and a phytotherapeutic agent. J Androl 2012;33(4):615-623. View summary.

Calabrese, V., Colombrita, C., Sultana, R., Scapagnini, G., Calvani, M., Butterfield, D. A., and Stella, A. M. Redox modulation of warmth shock protein expression by acetylcarnitine in getting older mind: relationship to antioxidant standing and mitochondrial operate. Antioxid.Redox.Sign. 2006;8(3-4):404-416. View summary.

Calabrese, V., Cornelius, C., Mancuso, C., Lentile, R., Stella, A. M., and Butterfield, D. A. Redox homeostasis and mobile stress response in getting older and neurodegeneration. Strategies Mol.Biol. 2010;610:285-308. View summary.

Calabrese, V., Cornelius, C., Stella, A. M., and Calabrese, E. J. Mobile stress responses, mitostress and carnitine insufficiencies as important determinants in getting older and neurodegenerative issues: function of hormesis and vitagenes. Neurochem.Res. 2010;35(12):1880-1915. View summary.

Calabrese, V., Giuffrida Stella, A. M., Calvani, M., and Butterfield, D. A. Acetylcarnitine and mobile stress response: roles in dietary redox homeostasis and regulation of longevity genes. J Nutr.Biochem. 2006;17(2):73-88. View summary.

Calandrella, N., De, Seta C., Scarsella, G., and Risuleo, G. Carnitine reduces the lipoperoxidative injury of the membrane and apoptosis after induction of cell stress in experimental glaucoma. Cell Loss of life.Dis 2010;1:e62. View summary.

Calo, L. A., Pagnin, E., Davis, P. A., Semplicini, A., Nicolai, R., Calvani, M., and Pessina, A. C. Antioxidant impact of L-carnitine and its brief chain esters: relevance for the safety from oxidative stress associated cardiovascular injury. Int.J Cardiol. 2-8-2006;107(1):54-60. View summary.

Cao, Y., Wang, Y. X., Liu, C. J., Wang, L. X., Han, Z. W., and Wang, C. B. Comparability of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in wholesome volunteers. Clin Make investments Med. 2009;32(1):E13-E19. View summary.

Carlsson, M., Forsberg, E., and Thorne, A. Observations throughout L-carnitine infusion in two long-term critically sick sufferers. Clin Physiol 1984;4(4):363-365. View summary.

Carroll, J. Okay., Kohli, S., Mustian, Okay. M., Roscoe, J. A., and Morrow, G. R. Pharmacologic remedy of cancer-related fatigue. Oncologist. 2007;12 Suppl 1:43-51. View summary.

Caruso U, Cravotto E, Tisone G, and et al. Lengthy-term remedy with L-carnitine in uremic sufferers present process power hemodialysis: results on the lipid sample. Present Therapeutic Reserch 1983;33(6):1098-1104.

Caruso U, Leone L Cravotto E Nava D. Results of L-carnitine on anemia in aged hemodialysis sufferers handled with recombinant human erythropoietin: A pilot research. Dial Transplant 1998;27:498-506.

Casciani CU, Caruso U, Cravotto E, and et al. Helpful results of L-carnitine in put up dialysis syndrome. Curr Ther res, Clin exp 1982;32(11):116-127.

Casciani, C. U., Caruso, U., Cravotto, E., Corsi, M., Pola, P., Savi, L., and Grilli, M. Impact of L-carnitine on lipid sample in haemodialysis. Lancet 12-13-1980;2(8207):1309-1310. View summary.

Casciani, C. U., Caruso, U., Cravotto, E., D’Iddio, S., Corsi, M., Pola, P., Savi, L., and Grilli, M. L-carnitine in haemodialysed sufferers. Adjustments in lipid sample. Arzneimittelforschung 1982;32(3):293-297. View summary.

Cavallini, G., Ferraretti, A. P., Gianaroli, L., Biagiotti, G., and Vitali, G. Cinnoxicam and L-carnitine/acetyl-L-carnitine remedy for idiopathic and varicocele-associated oligoasthenospermia. J Androl 2004;25(5):761-770. View summary.

Cetinkaya, A., Bulbuloglu, E., Kantarceken, B., Ciralik, H., Kurutas, E. B., Buyukbese, M. A., and Gumusalan, Y. Results of L-carnitine on oxidant/antioxidant standing in acetic acid-induced colitis. Dig.Dis Sci 2006;51(3):488-494. View summary.

Cha, Y. S., Choi, S. Okay., Suh, H., Lee, S. N., Cho, D., and Li, Okay. Results of carnitine coingested caffeine on carnitine metabolism and endurance capability in athletes. J Nutr Sci Vitaminol.(Tokyo) 2001;47(6):378-384. View summary.

Chan, A., Paskavitz, J., Remington, R., Rasmussen, S., and Shea, T. B. Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer’s illness: a 1-year, open-label pilot research with an 16-month caregiver extension. Am.J Alzheimers.Dis Different Demen. 12-20-2008;23(6):571-585. View summary.

Chan, A., Remington, R., Kotyla, E., Lepore, A., Zemianek, J., and Shea, T. B. A vitamin/nutriceutical formulation improves reminiscence and cognitive efficiency in community-dwelling adults with out dementia. J.Nutr.Well being Getting old 2010;14(3):224-230. View summary.

Chan, Y. C., Tse, M. L., and Lau, F. L. Two circumstances of valproic acid poisoning handled with L-carnitine. Hum.Exp.Toxicol. 2007;26(12):967-969. View summary.

Chao, H. H., Chen, C. H., Liu, J. C., Lin, J. W., Wong, Okay. L., and Cheng, T. H. L-Carnitine attenuates angiotensin II-induced proliferation of cardiac fibroblasts: function of NADPH oxidase inhibition and decreased sphingosine-1-phosphate technology. J Nutr.Biochem. 2010;21(7):580-588. View summary.

Chazot, C., Blanc, C., Hurot, J. M., Charra, B., Jean, G., and Laurent, G. Dietary results of carnitine supplementation in hemodialysis sufferers. Clin Nephrol 2003;59(1):24-30. View summary.

Chen, J. C., Tsai, T. C., Liu, C. S., and Lu, C. T. Acute listening to loss in a affected person with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Acta Neurol.Taiwan. 2007;16(3):168-172. View summary.

Chen, X. F., Li, Z., Ping, P., Dai, J. C., Zhang, F. B., and Shang, X. J. [Efficacy of natural vitamin E on oligospermia and asthenospermia: a prospective multi-centered randomized controlled study of 106 cases]. Zhonghua Nan.Ke.Xue 2012;18(5):428-431. View summary.

Cheng, H. J. and Chen, T. [Clinical efficacy of combined L-carnitine and acetyl-L-carnitine on idiopathic asthenospermia]. Zhonghua Nan.Ke.Xue. 2008;14(2):149-151. View summary.

Cipolli, C. and Chiari, G. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results]. Clin Ter 3-31-1990;132(6 Suppl):479-510. View summary.

Colon-Soto, M., Peredo, R. A., and Vila, L. M. Systemic lupus erythematosus after mesotherapy with acetyl-L-carnitine. J Clin Rheumatol. 2006;12(5):261-262. View summary.

Corbucci, G. G., Melis, A., Piga, M., Marchionni, A., and Calvani, M. Affect of acetyl-carnitine on some mitochondrial enzymic actions within the human cerebral tissue in situations of acute hypoxia. Int J Tissue React. 1992;14(4):183-194. View summary.

Corbucci, G. G., Menichetti, A., Cogliatti, A., Nicoli, P., and Ruvolo, C. Metabolic features of acute tissue hypoxia throughout extracorporeal circulation and their modification induced by L-carnitine remedy. Int J Clin Pharmacol Res 1992;12(3):149-157. View summary.

Corsi, C., Pollastri, M., Marrapodi, E., Leanza, D., Giordano, S., and D’Iddio, S. L-propionylcarnitine impact on postexercise and postischemic hyperemia in sufferers affected by peripheral vascular illness. Angiology 1995;46(8):705-713. View summary.

Costa, M., Canale, D., Filicori, M., D’lddio, S., and Lenzi, A. L-carnitine in idiopathic asthenozoospermia: a multicenter research. Italian Examine Group on Carnitine and Male Infertility. Andrologia 1994;26(3):155-159. View summary.

Coto V, D’Alessandro L, Grattarola G, and et al. Analysis of the therapeutic efficacy and tolerability of levocarnitine propionyl within the remedy of power obstructive arteriopathies of the decrease extremities: a multicentre managed research vs. placebo. Medicine Exptl Clin Res 1992;18(1):29-36.

Crentsil, V. Mechanistic contribution of carnitine deficiency to geriatric frailty. Ageing Res.Rev. 2010;9(3):265-268. View summary.

Crill, C. M., Christensen, M. L., Storm, M. C., and Helms, R. A. Relative bioavailability of carnitine supplementation in untimely neonates. JPEN J Parenter.Enteral Nutr. 2006;30(5):421-425. View summary.

Crill, C. M., Storm, M. C., Christensen, M. L., Hankins, C. T., Bruce, Jenkins M., and Helms, R. A. Carnitine supplementation in untimely neonates: impact on plasma and purple blood cell whole carnitine concentrations, vitamin parameters and morbidity. Clin Nutr. 2006;25(6):886-896. View summary.

Cruciani, R. A., Dvorkin, E., Homel, P., Culliney, B., Malamud, S., Lapin, J., Portenoy, R. Okay., and Esteban-Cruciani, N. L-carnitine supplementation in sufferers with superior most cancers and carnitine deficiency: a double-blind, placebo-controlled research. J Ache Symptom.Handle. 2009;37(4):622-631. View summary.

Cruciani, R. A., Dvorkin, E., Homel, P., Culliney, B., Malamud, S., Shaiova, L., Fleishman, S., Lapin, J., Klein, E., Lesage, P., Portenoy, R., and Esteban-Cruciani, N. L-carnitine supplementation for the remedy of fatigue and depressed temper in most cancers sufferers with carnitine deficiency: a preliminary evaluation. Ann N.Y.Acad.Sci 2004;1033:168-176. View summary.

Csiky, B., Nyul, Z., Toth, G., Wittmann, I., Melegh, B., Rauh, M., Rascher, W., and Sulyok, E. L-carnitine supplementation and adipokines in sufferers with end-stage renal illness on common hemodialysis. Exp.Clin Endocrinol.Diabetes 2010;118(10):735-740. View summary.

Cucinotta D, Passeri M, Ventura S, and et al. Multicenter medical placebo-controlled research with acetyl-L-carnitine within the remedy of mildly demented aged sufferers. Drug Dev Res 1988;14:213-216.

Cui, G., Xu, W. H., and Wu.G.P. Results of wuzi yanzong liquids combing with L-carnitine on oligospermia and asthenospermia. J.HainanMed.School 2011;17(3):347-349.

Curran, J. S., Williams, P. R., Kanarek, Okay. S., Novak, M., and Monkus, E. F. An analysis of orally supplemented L-carnitine in untimely infants receiving Intralipid 20%. Acta Chir Scand Suppl 1983;517:157-164. View summary.

Cuturic, M., Abramson, R. Okay., Moran, R. R., and Hardin, J. W. Medical outcomes and low-dose levocarnitine supplementation in psychiatric inpatients with documented hypocarnitinemia: a retrospective chart assessment. J Psychiatr.Pract. 2010;16(1):5-14. View summary.

Dal Negro R, Pomari G, Zoccatelli O, and et al. Adjustments in bodily efficiency of untrained volunteers: results of L-carnitine. Medical Trials Journal 1986;23(4):242-248.

Dal Negro, R., Turco, P., Pomari, C., and De Conti, F. Results of L-carnitine on bodily efficiency in power respiratory insufficiency. Int J Clin Pharmacol Ther Toxicol. 1988;26(5):269-272. View summary.

de Lira-Garcia, C., Souto-Gallardo, M., Bacardi-Gascon, M., and Jimenez-Cruz, A. [A systematic review of the effectiveness of alternative weight-loss products’ ingredients]. Rev.Salud Publica (Bogota.) 2008;10(5):818-830. View summary.

De Marchi, S., Zecchetto, S., Rigoni, A., Prior, M., Fondrieschi, L., Scuro, A., Rulfo, F., and Arosio, E. Propionyl-L-carnitine improves endothelial operate, microcirculation and ache administration in important limb ischemia. Cardiovasc.Medicine Ther 2012;26(5):401-408. View summary.

De Pasquale, B., Righetti, G., and Menotti, A. [L-carnitine for the treatment of acute myocardial infarct]. Cardiologia 1990;35(7):591-596. View summary.

De Ritis G, Picardo S, Brancadoro D, and et al. The impact of carnitine in sufferers utilizing synthetic pacemakers. Present Therapeutic Analysis 1989;46(6):1027-1033.

De Simone C, Catania S, Trinchieri V, and et al. Amelioration of the despair of HIV-infected topics with L-acetyl carnitine remedy. J Drug Dev 1988;1(3):163-166.

De Simone, C., Tzantzoglou, S., Famularo, G., Moretti, S., Paoletti, F., Vullo, V., and Delia, S. Excessive dose L-carnitine improves immunologic and metabolic parameters in AIDS sufferers. Immunopharmacol.Immunotoxicol. 1993;15(1):1-12. View summary.

De Vecchi, A. F., Arduini, A., Di, Liberato L., and Bonomini, M. [L-carnitine in peritoneal dialysis]. G.Ital.Nefrol. 2011;28(4):393-400. View summary.

Dealberto, M. J. Valproate-induced hyperammonaemic encephalopathy: assessment of 14 circumstances within the psychiatric setting. Int.Clin Psychopharmacol. 2007;22(6):330-337. View summary.

Decombaz, J., Deriaz, O., Acheson, Okay., Gmuender, B., and Jequier, E. Impact of L-carnitine on submaximal train metabolism after depletion of muscle glycogen. Med Sci Sports activities Exerc. 1993;25(6):733-740. View summary.

DeFelice SL and Gilgore SG. The antagonistic impact of carnitine in hyperthyroidism. Preliminary report. Journal of New Medicine 1966;6(6):351-353.

del Olmo, J. A., Castillo, M., Rodrigo, J. M., Aparisi, L., Serra, M. A., Wassel, A., and Bixquert, M. Impact of L-carnitine upon ammonia tolerance take a look at in cirrhotic sufferers. Adv Exp Med Biol 1990;272:197-208. View summary.

Demeyere, R., Lormans, P., Weidler, B., Minten, J., Van Aken, H., and Flameng, W. Cardioprotective results of carnitine in intensive aortocoronary bypass grafting: a double-blind, randomized, placebo-controlled medical trial. Anesth.Analg. 1990;71(5):520-528. View summary.

Derosa, G., Cicero, A. F., Gaddi, A., Mugellini, A., Ciccarelli, L., and Fogari, R. The impact of L-carnitine on plasma lipoprotein(a) ranges in hypercholesterolemic sufferers with sort 2 diabetes mellitus. Clin Ther 2003;25(5):1429-1439. View summary.

Derosa, G., Maffioli, P., Ferrari, I., D’Angelo, A., Fogari, E., Palumbo, I., Randazzo, S., and Cicero, A. F. Comparability between orlistat plus l-carnitine and orlistat alone on irritation parameters in overweight diabetic sufferers. Fundam.Clin Pharmacol 2011;25(5):642-651. View summary.

Derosa, G., Maffioli, P., Ferrari, I., D’Angelo, A., Fogari, E., Palumbo, I., Randazzo, S., and Cicero, A. F. Orlistat and L-carnitine in comparison with orlistat alone on insulin resistance in overweight diabetic sufferers. Endocr.J 2010;57(9):777-786. View summary.

Derosa, G., Maffioli, P., Salvadeo, S. A., Ferrari, I., Gravina, A., Mereu, R., D’Angelo, A., Palumbo, I., Randazzo, S., and Cicero, A. F. Results of mixture of sibutramine and L-carnitine in contrast with sibutramine monotherapy on inflammatory parameters in diabetic sufferers. Metabolism 2011;60(3):421-429. View summary.

Derosa, G., Maffioli, P., Salvadeo, S. A., Ferrari, I., Gravina, A., Mereu, R., D’Angelo, A., Palumbo, I., Randazzo, S., and Cicero, A. F. Sibutramine and L-carnitine in comparison with sibutramine alone on insulin resistance in diabetic sufferers. Intern.Med 2010;49(16):1717-1725. View summary.

Desbree, A., Houdon, L., Touati, G., Djemili, S., Choker, G., and Flodrops, H. [EBV infection revealing a long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency in a 3-year-old boy]. Arch.Pediatr. 2011;18(1):18-22. View summary.

Digiesi, V., Palchetti, R., and Cantini, F. [The benefits of L-carnitine therapy in essential arterial hypertension with diabetes mellitus type II]. Minerva Med 1989;80(3):227-231. View summary.

DiMauro, S. and Hirano, M. Mitochondrial DNA Deletion Syndromes. In: Pagon, R. A., Fowl, T. D., Dolan, C. R., Stephens, Okay., and Adam, M. P. GeneReviews [Internet]. Seattle, WA: College of Washington, Seattle;1993. View summary.

Dimitriadis, F., Tsambalas, S., Tsounapi, P., Kawamura, H., Vlachopoulou, E., Haliasos, N., Gratsias, S., Watanabe, T., Saito, M., Miyagawa, I., and Sofikitis, N. Results of phosphodiesterase-5 inhibitors on Leydig cell secretory operate in oligoasthenospermic infertile males: a randomized trial. BJU.Int. 2010;106(8):1181-1185. View summary.

DiNicolantonio, J. J., Lavie, C. J., Fares, H., Menezes, A. R., and O’Keefe, J. H. L-carnitine within the secondary prevention of heart problems: systematic assessment and meta-analysis. Mayo Clin Proc. 2013;88(6):544-551. View summary.

Dokmeci, D., Inan, M., Basaran, U. N., Yalcin, O., Aydogdu, N., Turan, F. N., and Uz, Y. H. Protecting impact of L-carnitine on testicular ischaemia-reperfusion damage in rats. Cell Biochem.Funct. 2007;25(6):611-618. View summary.

Donnelly, C. T., Hameed, A. B., Abdenur, J. E., and Wing, D. A. Carnitine deficiency in being pregnant. Obstet.Gynecol. 2007;110(2 Pt 2):480-482. View summary.

Dragan, A. M., Vasiliu, D., Eremia, N. M., and Georgescu, E. Research regarding some acute organic adjustments after endovenous administration of 1 g l-carnitine, in elite athletes. Physiologie. 1987;24(4):231-234. View summary.

Dragan, G. I., Vasiliu, A., Georgescu, E., and Dumas, I. Research regarding power and acute results of L-carnitine on some organic parameters in elite athletes. Physiologie. 1987;24(1):23-28. View summary.

Dragan, I. G., Vasiliu, A., Georgescu, E., and Eremia, N. Research regarding power and acute results of L-carnitina in elite athletes. Physiologie. 1989;26(2):111-129. View summary.

Duranay, M., Akay, H., Yilmaz, F. M., Senes, M., Tekeli, N., and Yucel, D. Results of L-carnitine infusions on inflammatory and dietary markers in haemodialysis sufferers. Nephrol.Dial Transplant 2006;21(11):3211-3214. View summary.

Dutta, A., Ray, Okay., Singh, V. Okay., Vats, P., Singh, S. N., and Singh, S. B. L-carnitine supplementation attenuates intermittent hypoxia-induced oxidative stress and delays muscle fatigue in rats. Exp.Physiol 2008;93(10):1139-1146. View summary.

Eidi, M., Pouyan, O., Shahmohammadi, P., Saeidi, H., Bahar, M., and Eidi, A. Impact of L-carnitine complement on semen parameters in males with idiopathic infertility. J.Med.Sci.J.Islamic Azad Univ. 2009;19(1):Pe11-Pe15.

El Beshlawy, A., Abd, El Raouf, Mostafa, F., Talaat, M., Isma’eel, H., Aoun, E., Hoffbrand, A. V., and Taher, A. Diastolic dysfunction and pulmonary hypertension in sickle cell anemia: is there a job for L-carnitine remedy? Acta Haematol. 2006;115(1-2):91-96. View summary.

El Beshlawy, A., Mohtar, G., Abd El, Ghafar E., Abd El Dayem, S. M., El Sayed, M. H., Aly, A. A., and Farok, M. Evaluation of puberty in relation to L-carnitine and hormonal alternative remedy in beta-thalassemic sufferers. J Trop.Pediatr. 2008;54(6):375-381. View summary.

El-Beshlawy, A., El, Accaoui R., Abd El-Sattar, M., Gamal El-Deen, M. H., Youssry, I., Shaheen, N., Hamdy, M., El-Ghamrawy, M., and Taher, A. Impact of L-carnitine on the bodily health of thalassemic sufferers. Ann.Hematol. 2007;86(1):31-34. View summary.

El-Beshlawy, A., Youssry, I., El-Saidi, S., El, Accaoui R., Mansi, Y., Makhlouf, A., and Taher, A. Pulmonary hypertension in beta-thalassemia main and the function of L-carnitine remedy. Pediatr.Hematol.Oncol. 2008;25(8):734-743. View summary.

El-Metwally, T. H., Hamed, E. A., Ahmad, A. R., and Mohamed, N. A. Dyslipidemia, oxidative stress and cardiac dysfunction in youngsters with power renal failure: results of L-carnitine supplementation. Ann.Saudi.Med. 2003;23(5):270-277. View summary.

Ellaway, C. J., Peat, J., Williams, Okay., Leonard, H., and Christodoulou, J. Medium-term open label trial of L-carnitine in Rett syndrome. Mind Dev. 2001;23 Suppl 1:S85-S89. View summary.

Elmslie, J. L., Porter, R. J., Joyce, P. R., Hunt, P. J., and Mann, J. I. Carnitine doesn’t enhance weight reduction outcomes in valproate-treated bipolar sufferers consuming an energy-restricted, low-fat food plan. Bipolar.Disord. 2006;8(5 Pt 1):503-507. View summary.

Erbas, H., Aydogdu, N., Usta, U., and Erten, O. Protecting function of carnitine in breast most cancers by way of lowering arginase exercise and growing nitric oxide. Cell Biol.Int. 2007;31(11):1414-1419. View summary.

Eroglu, H., Senel, O., and Guzel, N. A. Results of acute L-carnitine consumption on metabolic and blood lactate ranges of elite badminton gamers. Neuro.Endocrinol.Lett. 2008;29(2):261-266. View summary.

Evangelista, M., Koverech, A., Messano, M., and Pescosolido, N. Comparability of three lubricant eye drop options in dry eye sufferers. Optom.Vis.Sci 2011;88(12):1439-1444. View summary.

Evans, J. D., Jacobs, T. F., and Evans, E. W. Function of acetyl-L-carnitine within the remedy of diabetic peripheral neuropathy. Ann.Pharmacother. 2008;42(11):1686-1691. View summary.

Fagher, B., Cederblad, G., Eriksson, M., Monti, M., Moritz, U., Nilsson-Ehle, P., and Thysell, H. L-carnitine and haemodialysis: double blind research on muscle operate and metabolism and peripheral nerve operate. Scand.J Clin Lab Make investments 1985;45(2):169-178. View summary.

Fagher, B., Cederblad, G., Monti, M., Olsson, L., Rasmussen, B., and Thysell, H. Carnitine and left ventricular operate in haemodialysis sufferers. Scand.J Clin Lab Make investments 1985;45(3):193-198. View summary.

Fagher, B., Thysell, H., Nilsson-Ehle, P., Monti, M., Olsson, L., Eriksson, M., Lindstedt, S., and Lindholm, T. The impact of D,L-carnitine supplementation on muscle metabolism, neuropathy, cardiac and hepatic operate in hemodialysis sufferers. A pilot research. Acta Med Scand 1982;212(3):115-120. View summary.

Famularo, G., Moretti, S., Alesse, E., Trinchieri, V., Angelucci, A., Santini, G., Cifone, G., and De, Simone C. Discount of glutamate ranges in HIV-infected topics handled with acetylcarnitine. J NeuroAIDS. 1999;2(2):65-73. View summary.

Fan, J. P., Kim, H. S., and Han, G. D. Induction of apoptosis by L-carnitine via regulation of two predominant pathways in Hepa1c1c 7 cells. Amino.Acids 2009;36(2):365-372. View summary.

Faria, C. C., Mota, J. F., Paula Ravagnani, F. C., and Burini, R. C. [The supplementation of L-carnitine does not promote alterations in the resting metabolic rate and in the use of energetic substrates in physically active individuals]. Arq Bras.Endocrinol.Metabol. 2010;54(1):37-44. View summary.

Fatouros, I. G., Douroudos, I., Panagoutsos, S., Pasadakis, P., Nikolaidis, M. G., Chatzinikolaou, A., Sovatzidis, A., Michailidis, Y., Jamurtas, A. Z., Mandalidis, D., Taxildaris, Okay., and Vargemezis, V. Results of L-carnitine on oxidative stress responses in sufferers with renal illness. Med.Sci Sports activities Exerc. 2010;42(10):1809-1818. View summary.

Feillet, F., Ogier, H., Cheillan, D., Aquaviva, C., Labarthe, F., Baruteau, J., Chabrol, B., de, Lonlay P., Valayanopoulos, V., Garnotel, R., Dobbelaere, D., Briand, G., Jeannesson, E., Vassault, A., and Vianey-Saban, C. [Medium-chain acyl-CoA-dehydrogenase (MCAD) deficiency: French consensus for neonatal screening, diagnosis, and management]. Arch.Pediatr 2012;19(2):184-193. View summary.

Feinfeld, D. A., Kurian, P., Cheng, J. T., Dilimetin, G., Arriola, M. R., Ward, L., Manis, T., and Carvounis, C. P. Impact of oral L-carnitine on serum myoglobin in hemodialysis sufferers. Ren Fail. 1996;18(1):91-96. View summary.

Fenkci, S. M., Fenkci, V., Oztekin, O., Rota, S., and Karagenc, N. Serum whole L-carnitine ranges in non-obese girls with polycystic ovary syndrome. Hum.Reprod. 2008;23(7):1602-1606. View summary.

Fernandez, C. and Proto, C. [L-carnitine in the treatment of chronic myocardial ischemia. An analysis of 3 multicenter studies and a bibliographic review]. Clin Ter. 1992;140(4):353-377. View summary.

Ferrari R, Cucchini F, Dilisa F, and et al. The impact of L-carnitine (carnitene) on myocardial metabolism of sufferers with coronary artery illness. Clin Trial J 1984;21:40-58.

Fietta, P. and Manganelli, P. Carnitine: a therapeutic possibility for childhood psoriatic onycho-pachydermo-periostitis (POPP). Clin Rheumatol. 2007;26(1):93-94. View summary.

Filipek, P. A., Juranek, J., Nguyen, M. T., Cummings, C., and Gargus, J. J. Relative carnitine deficiency in autism. J Autism Dev.Disord. 2004;34(6):615-623. View summary.

Foitzik, Okay., Hoting, E., Heinrich, U., Tronnier, H., and Paus, R. Indications that topical L-carnitin-L-tartrate promotes human hair progress in vivo. J Dermatol.Sci 2007;48(2):141-144. View summary.

Footitt, E. J., Stafford, J., Dixon, M., Burch, M., Jakobs, C., Salomons, G. S., and Cleary, M. A. Use of a long-chain triglyceride-restricted/medium-chain triglyceride-supplemented food plan in a case of malonyl-CoA decarboxylase deficiency with cardiomyopathy. J Inherit.Metab Dis 6-15-2010; View summary.

Fornasini, G., Upton, R. N., and Evans, A. M. A pharmacokinetic mannequin for L-carnitine in sufferers receiving haemodialysis. Br.J Clin Pharmacol 2007;64(3):335-345. View summary.

Fortin, G., Yurchenko, Okay., Collette, C., Rubio, M., Villani, A. C., Bitton, A., Sarfati, M., and Franchimont, D. L-carnitine, a food plan part and natural cation transporter OCTN ligand, shows immunosuppressive properties and abrogates intestinal irritation. Clin Exp.Immunol. 2009;156(1):161-171. View summary.

Fujiwara, M., Nakano, T., Tamoto, S., Yamada, Y., Fukai, M., Takada, Okay., Ashida, H., Shimada, T., Ishihara, T., and Seki, I. [Effect of L-carnitine in patients with ischemic heart disease]. J Cardiol 1991;21(2):493-504. View summary.

Fulgente T, Onofrj M Del Re ML et al. Laevo-acetylcarnitine (Nicetile registered) remedy of senile despair. Clin Trials J 1990;27:155-163.

Galvano, F., Li, Volti G., Malaguarnera, M., Avitabile, T., Antic, T., Vacante, M., and Malaguarnera, M. Results of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in sort 2 diabetes mellitus. Professional.Opin.Pharmacother. 2009;10(12):1875-1882. View summary.

Ganio, M. S., Klau, J. F., Lee, E. C., Yeargin, S. W., McDermott, B. P., Buyckx, M., Maresh, C. M., and Armstrong, L. E. Impact of assorted carbohydrate-electrolyte fluids on biking efficiency and maximal voluntary contraction. Int J Sport Nutr Exerc.Metab 2010;20(2):104-114. View summary.

Gecele M, Francesetti G, and Meluzzi A. Acetyl-L-carnitine in aged topics with main despair: medical efficacy and results on the circadian rhythm of cortisol. Dementia 1991;2(6):333-337.

Geier, D. A., Kern, J. Okay., Davis, G., King, P. G., Adams, J. B., Younger, J. L., and Geier, M. R. A potential double-blind, randomized medical trial of levocarnitine to deal with autism spectrum issues. Med.Sci Monit. 2011;17(6):I15-I23. View summary.

Genazzani, A. D., Lanzoni, C., Ricchieri, F., Santagni, S., Rattighieri, E., Chierchia, E., Monteleone, P., and Jasonni, V. M. Acetyl-L-carnitine (ALC) administration positively impacts reproductive axis in hypogonadotropic girls with useful hypothalamic amenorrhea. J Endocrinol.Make investments 2011;34(4):287-291. View summary.

Genger, H., Enzelsberger, H., and Salzer, H. [Carnitine in therapy of placental insufficiency–initial experiences]. Z Geburtshilfe Perinatol. 1988;192(4):155-157. View summary.

Gentile, V., Antonini, G., Antonella, Bertozzi M., Dinelli, N., Rizzo, C., Ashraf, Virmani M., and Koverech, A. Impact of propionyl-L-carnitine, L-arginine and nicotinic acid on the efficacy of vardenafil within the remedy of erectile dysfunction in diabetes. Curr Med Res Opin. 2009;25(9):2223-2228. View summary.

Gesuete, V., Ragni, L., and Picchio, F. M. [The “big heart” of carnitine]. G.Ital.Cardiol.(Rome) 2010;11(9):703-705. View summary.

Giamberardino, M. A., Dragani, L., Valente, R., di Lisa, F., Saggini, R., and Vecchiet, L. Results of extended L-carnitine administration on delayed muscle ache and CK launch after eccentric effort. Int J Sports activities Med 1996;17(5):320-324. View summary.

Giammusso B, Morgia G, Spampinato A, and et al. Improved pallesthetic sensitivity of pudendal nerve in impotent diabetic sufferers handled with acetyl-L-carnitine. Acta Urol Ital 1996;10(3):185-187.

Gibault, J. P., Frey, A., Guiraud, M., Schirardin, H., Bouletreau, P., and Bach, A. C. Results of L-carnitine infusion on intralipid clearance and utilization. Examine carried out in septic sufferers of an intensive care unit. JPEN J Parenter.Enteral Nutr 1988;12(1):29-34. View summary.

Goetz, C. G., Tanner, C. M., Cohen, J. A., Thelen, J. A., Carroll, V. S., Klawans, H. L., and Fariello, R. G. L-acetyl-carnitine in Huntington’s illness: double-blind placebo managed crossover research of drug results on motion dysfunction and dementia. Mov Disord. 1990;5(3):263-265. View summary.

Goldenberg, N. A., Krantz, M. J., and Hiatt, W. R. L-Carnitine plus cilostazol versus cilostazol alone for the remedy of claudication in sufferers with peripheral artery illness: a multicenter, randomized, double-blind, placebo-controlled trial. Vasc.Med 2012;17(3):145-154. View summary.

Golper, T. A., Wolfson, M., Ahmad, S., Hirschberg, R., Kurtin, P., Katz, L. A., Nicora, R., Ashbrook, D., and Kopple, J. D. Multicenter trial of L-carnitine in upkeep hemodialysis sufferers. I. Carnitine concentrations and lipid results. Kidney Int 1990;38(5):904-911. View summary.

Gomez-Amores, L., Mate, A., Miguel-Carrasco, J. L., Jimenez, L., Jos, A., Camean, A. M., Revilla, E., Santa-Maria, C., and Vazquez, C. M. L-carnitine attenuates oxidative stress in hypertensive rats. J Nutr.Biochem. 2007;18(8):533-540. View summary.

Gonzalez-Ortiz, M., Hernandez-Gonzalez, S. O., Hernandez-Salazar, E., and Martinez-Abundis, E. Impact of oral L-carnitine administration on insulin sensitivity and lipid profile in sort 2 diabetes mellitus sufferers. Ann.Nutr.Metab 2008;52(4):335-338. View summary.

Gorostiaga, E. M., Maurer, C. A., and Eclache, J. P. Lower in respiratory quotient throughout train following L-carnitine supplementation. Int J Sports activities Med 1989;10(3):169-174. View summary.

Gramignano, G., Lusso, M. R., Madeddu, C., Massa, E., Serpe, R., Deiana, L., Lamonica, G., Dessi, M., Spiga, C., Astara, G., Maccio, A., and Mantovani, G. Efficacy of l-carnitine administration on fatigue, dietary standing, oxidative stress, and associated high quality of life in 12 superior most cancers sufferers present process anticancer remedy. Diet 2006;22(2):136-145. View summary.

Grandis, D. D. Tolerability and efficacy of L-acetylcarnitine in sufferers with peripheral neuropathies: a short-term, open multicentre research. Clin Drug Investig. 1998;15(2):73-79. View summary.

Graziano F, Renato B, Catalano V, and et al. Potential function of levocarnitine supplementation for remedy of chemotherapy-induced fatigue in non-anemic most cancers sufferers. (pre-publication creator’s copy, by way of correspondence) 2002;1-14.

Greco, A. V., Mingrone, G., Bianchi, M., and Ghirlanda, G. Impact of propionyl-L-carnitine within the remedy of diabetic angiopathy: managed double blind trial versus placebo. Medicine Exp Clin Res 1992;18(2):69-80. View summary.

Greig, C., Finch, Okay. M., Jones, D. A., Cooper, M., Sargeant, A. J., and Forte, C. A. The impact of oral supplementation with L-carnitine on most and submaximum train capability. Eur J Appl Physiol Occup.Physiol 1987;56(4):457-460. View summary.

Guan, Y., Zheng, X. M., Yang, Z. W., and Li, S. W. [Protective effects of L-carnitine upon testicular ischemia-reperfusion damage in rats]. Zhonghua Yi.Xue.Za Zhi. 7-14-2009;89(26):1858-1861. View summary.

Guarnieri, G. F., Ranieri, F., Toigo, G., Vasile, A., Ciman, M., Rizzoli, V., Moracchiello, M., and Campanacci, L. Lipid-lowering impact of carnitine in chronically uremic sufferers handled with upkeep hemodialysis. Am J Clin Nutr 1980;33(7):1489-1492. View summary.

Guevara-Campos, J., Gonzalez-Guevara, L., Parada, Y., and Urbaez-Cano, J. [Infantile encephalopathy associated with the MELAS A3243G mutation. Case report]. Make investments Clin 2007;48(2):243-248. View summary.

Guideri, F., Acampa, M., Hayek, Y., and Zappella, M. Results of acetyl-L-carnitine on cardiac dysautonomia in Rett syndrome: prevention of sudden demise? Pediatr Cardiol 2005;26(5):574-577. View summary.

Gunal, A. I., Celiker, H., Donder, E., and Gunal, S. Y. The impact of L-carnitine on insulin resistance in hemodialysed sufferers with power renal failure. J Nephrol. 1999;12(1):38-40. View summary.

Gurlek, A., Tutar, E., Akcil, E., Dincer, I., Erol, C., Kocaturk, P. A., and Oral, D. The consequences of L-carnitine remedy on left ventricular operate and erythrocyte superoxide dismutase exercise in sufferers with ischemic cardiomyopathy. Eur J Coronary heart Fail. 2000;2(2):189-193. View summary.

Gwak, J. H., Lee, J. H., Lee, S. J., Park, H. W., Kim, Y., and Hyun, Y. J. The impact of L-carnitine and isoflavone supplementation on weight discount and visceral fats accumulation in obese girls. Korean J.Diet 2007;40(7):630-638.

Hakeshzadeh, F., Tabibi, H., Ahmadinejad, M., Malakoutian, T., and Hedayati, M. Results of L-Carnitine complement on plasma coagulation and anticoagulation components in hemodialysis sufferers. Ren Fail. 2010;32(9):1109-1114. View summary.

Harper, P., Elwin, C. E., and Cederblad, G. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in wholesome topics. Eur J Clin Pharmacol 1988;35(5):555-562. View summary.

Hauck, E. W., Diemer, T., Schmelz, H. U., and Weidner, W. A important evaluation of nonsurgical remedy of Peyronie’s illness. Eur.Urol. 2006;49(6):987-997. View summary.

Head, E., Nukala, V. N., Fenoglio, Okay. A., Muggenburg, B. A., Cotman, C. W., and Sullivan, P. G. Results of age, dietary, and behavioral enrichment on mind mitochondria in a canine mannequin of human getting older. Exp.Neurol. 2009;220(1):171-176. View summary.

Heil, S. G., Hogeveen, M., Kluijtmans, L. A., van Dijken, P. J., van de Berg, G. B., Blom, H. J., and Morava, E. Marfanoid options in a baby with mixed methylmalonic aciduria and homocystinuria (CblC sort). J Inherit.Metab Dis 2007;30(5):811. View summary.

Heller, W., Musil, H. E., Gaebel, G., Hempel, V., Krug, W., and Kohn, H. J. [Effect of L-carnitine on post-stress metabolism in surgical patients]. Infusionsther.Klin.Ernahr. 1986;13(6):268-276. View summary.

Helms, R. A., Mauer, E. C., Hay, W. W., Jr., Christensen, M. L., and Storm, M. C. Impact of intravenous L-carnitine on progress parameters and fats metabolism throughout parenteral vitamin in neonates. JPEN J Parenter.Enteral Nutr 1990;14(5):448-453. View summary.

Helms, R. A., Whitington, P. F., Mauer, E. C., Catarau, E. M., Christensen, M. L., and Borum, P. R. Enhanced lipid utilization in infants receiving oral L-carnitine throughout long-term parenteral vitamin. J Pediatr 1986;109(6):984-988. View summary.

Heringer, J., Boy, S. P., Ensenauer, R., Assmann, B., Zschocke, J., Harting, I., Lucke, T., Maier, E. M., Muhlhausen, C., Haege, G., Hoffmann, G. F., Burgard, P., and Kolker, S. Use of pointers improves the neurological consequence in glutaric aciduria sort I. Ann.Neurol. 2010;68(5):743-752. View summary.

Herrmann, W. M., Dietrich, B., and Hiersemenzel, R. Pharmaco-electroencephalographic and medical results of the cholinergic substance–acetyl-L-carnitine–in sufferers with natural mind syndrome. Int J Clin Pharmacol Res 1990;10(1-2):81-84. View summary.

Hiatt, W. R., Creager, M. A., Amato, A., and Brass, E. P. Impact of propionyl-L-carnitine on a background of monitored train in sufferers with claudication secondary to peripheral artery illness. J Cardiopulm.Rehabil.Prev. 2011;31(2):125-132. View summary.

Hlais, S., Reslan, D. R., Sarieddine, H. Okay., Nasreddine, L., Taan, G., Azar, S., and Obeid, O. A. Impact of lysine, vitamin B(6), and carnitine supplementation on the lipid profile of male sufferers with hypertriglyceridemia: a 12-week, open-label, randomized, placebo-controlled trial. Clin Ther 2012;34(8):1674-1682. View summary.

Ho, J. Y., Kraemer, W. J., Volek, J. S., Fragala, M. S., Thomas, G. A., Dunn-Lewis, C., Coday, M., Hakkinen, Okay., and Maresh, C. M. l-Carnitine l-tartrate supplementation favorably impacts biochemical markers of restoration from bodily exertion in middle-aged women and men. Metabolism 2010;59(8):1190-1199. View summary.

Hoffman, J. R., Ratamess, N. A., Gonzalez, A., Beller, N. A., Hoffman, M. W., Olson, M., Purpura, M., and Jager, R. The consequences of acute and extended CRAM supplementation on response time and subjective measures of focus and application in wholesome faculty college students. J Int.Soc.Sports activities Nutr. 2010;7:39. View summary.

Holzhauer, P. Casuistry: medical vitamin intervention with particular micronutrient and train remedy in pancreatic most cancers. Zeitschrift für Orthomolekulare Medizin 2009;7(3):22-24.

Hooshmand, S., Balakrishnan, A., Clark, R. M., Owen, Okay. Q., Koo, S. I., and Arjmandi, B. H. Dietary l-carnitine supplementation improves bone mineral density by suppressing bone turnover in aged ovariectomized rats. Phytomedicine. 2008;15(8):595-601. View summary.

Horvath, G. A., Davidson, A. G., Stockler-Ipsiroglu, S. G., Lillquist, Y. P., Waters, P. J., Olpin, S., Andresen, B. S., Palaty, J., Nelson, J., and Vallance, H. New child screening for MCAD deficiency: expertise of the primary three years in British Columbia, Canada. Can.J Public Well being 2008;99(4):276-280. View summary.

Hsieh, C. T., Hwu, W. L., Huang, Y. T., Huang, A. C., Wang, S. F., Hu, M. H., and Chien, Y. H. Early detection of glutaric aciduria sort I by new child screening in Taiwan. J Formos.Med.Assoc. 2008;107(2):139-144. View summary.

Huang, W. W., Wang, M. Y., Shi, H. M., Peng, Y., Peng, C. S., Zhang, M., Li, Y., Lu, J., and Li, X. B. Comparative research of bioactive constituents in crude and processed Glycyrrhizae radix and their respective metabolic profiles in gastrointestinal tract in vitro by HPLC-DAD and HPLC-ESI/MS analyses. Arch.Pharm Res 2012;35(11):1945-1952. View summary.

Huang, Y., Huang, L. C., and Zhan, F. Medical evaluation of therapeutic impact of levocarnitine on dialysis sufferers. China Tropical Med 2007;7(5):753-754.

Huidekoper, H. H., Schneider, J., Westphal, T., Vaz, F. M., Duran, M., and Wijburg, F. A. Extended moderate-intensity train with out and with L-carnitine supplementation in sufferers with MCAD deficiency. J Inherit.Metab Dis 2006;29(5):631-636. View summary.

Ishii, Okay., Komaki, H., Ohkuma, A., Nishino, I., Nonaka, I., and Sasaki, M. Central nervous system and muscle involvement in an adolescent affected person with riboflavin-responsive a number of acyl-CoA dehydrogenase deficiency. Mind Dev. 2010;32(8):669-672. View summary.

Isidori, A. M., Pozza, C., Gianfrilli, D., and Isidori, A. Medical remedy to enhance sperm high quality. Reprod.Biomed.On-line. 2006;12(6):704-714. View summary.

Iyer, R. N., Khan, A. A., Gupta, A., Vajifdar, B. U., and Lokhandwala, Y. Y. L-carnitine reasonably improves the train tolerance in power steady angina. J Assoc Physicians India 2000;48(11):1050-1052. View summary.

Iyer, R., Gupta, A., Khan, A., Hiremath, S., and Lokhandwala, Y. Does left ventricular operate enhance with L-carnitine after acute myocardial infarction? J Postgrad Med 1999;45(2):38-41. View summary.

Jacoba KG, Abarquez RF, Topacio GO, and et al. Impact of L-carnitine on the limitation of infarct dimension in one-month postmyocardial infarction circumstances. A multicentre, randomized, parallel, placebo-controlled trial. Clin Drug Make investments 1996;11(2):90-96.

Jacobs, P. L. and Goldstein, E. R. Lengthy-term glycine propionyl-l-carnitine supplemention and paradoxical results on repeated anaerobic dash efficiency. J Int.Soc.Sports activities Nutr. 2010;7:35. View summary.

Jacobs, P. L., Goldstein, E. R., Blackburn, W., Orem, I., and Hughes, J. J. Glycine propionyl-L-carnitine produces enhanced anaerobic work capability with lowered lactate accumulation in resistance skilled males. J Int.Soc.Sports activities Nutr. 2009;6:9. View summary.

Janiri, L., Martinotti, G., Tonioni, F., Ghelardini, C., Nicolai, R., Galeotti, N., Mosconi, L., Calvani, M., Bartolini, A., and Iannoni, E. Acetyl-L-carnitine within the administration of ache throughout methadone withdrawal syndrome. Clin Neuropharmacol. 2009;32(1):35-40. View summary.

Jimenez Caballero, P. E. and Marsal, Alonso C. [Type 1 glutaric aciduria: clinical and therapeutic implications]. Neurologia 2007;22(5):329-332. View summary.

Jing, L., Li, W. M., Zhou, L. J., and Tune, J. [L-carnitine and cardiac metabolism and remodeling indices in alcoholic cardiomyopathy]. Zhonghua Nei Ke.Za Zhi. 2008;47(11):934-937. View summary.

Jing, L., Zhou, L. J., Li, W. M., Zhang, F. M., Yuan, L., Li, S., Tune, J., and Sang, Y. Carnitine regulates myocardial metabolism by Peroxisome Proliferator-Activated Receptor-alpha (PPARalpha) in alcoholic cardiomyopathy. Med.Sci Monit. 2011;17(1):BR1-BR9. View summary.

Jirillo, E., Altamura, M., Munno, I., Pellegrino, N. M., Sabato, R., Di Fabio, S., and De Simone, C. Results of acetyl-L-carnitine oral administration on lymphocyte antibacterial exercise and TNF-alpha ranges in sufferers with lively pulmonary tuberculosis. A randomized double blind versus placebo research. Immunopharmacol.Immunotoxicol. 1991;13(1-2):135-146. View summary.

Jones, S., Reed, C. A., Vijay, S., Walter, J. H., and Morris, A. A. N-carbamylglutamate for neonatal hyperammonaemia in propionic acidaemia. J Inherit.Metab Dis 2008;31 Suppl 2:S219-S222. View summary.

Jung, J., Eo, E., and Ahn, Okay. O. A case of hemoperfusion and L-carnitine administration in valproic acid overdose. Am.J Emerg.Med. 2008;26(3):388-4. View summary.

Kamikawa, T., Suzuki, Y., Kobayashi, A., Hayashi, H., Masumura, Y., Nishihara, Okay., Abe, M., and Yamazaki, N. Results of L-carnitine on train tolerance in sufferers with steady angina pectoris. Jpn Coronary heart J 1984;25(4):587-597. View summary.

Kang, H. C., Kim, H. D., Lee, Y. M., and Han, S. H. Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency. Pediatr.Neurol. 2006;35(2):158-161. View summary.

Karahan, M., Cokseym, B., and Arts, S. The impact of L-carnitine supplementation on 1500 m working efficiency. Ovidius College Annals, Bodily Schooling and Sport/Science, Motion and Well being Collection 2010;10(Suppl 2):504-507.

Karanth, J. and Jeevaratnam, Okay. Impact of carnitine supplementation on mitochondrial enzymes in liver and skeletal muscle of rat after dietary lipid manipulation and bodily exercise. Indian J Exp.Biol. 2010;48(5):503-510. View summary.

Karanth, J. and Jeevaratnam, Okay. Impact of dietary lipid, carnitine and train on lipid profile in rat blood, liver and muscle. Indian J Exp.Biol. 2009;47(9):748-753. View summary.

Karimi, M., Mohammadi, F., Behmanesh, F., Samani, S. M., Borzouee, M., Amoozgar, H., and Haghpanah, S. Impact of mixture remedy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac operate of sufferers with beta-thalassemia intermedia. Eur.J Haematol. 1-1-2010;84(1):52-58. View summary.

Katiyar, A. and Aaron, C. Case information of the Youngsters’s Hospital of Michigan Regional Poison Management Middle: using carnitine for the administration of acute valproic acid toxicity. J Med.Toxicol. 2007;3(3):129-138. View summary.

Kaviani, M., Nourshahi, M., and Shokoohi, F. The consequences of acute L-carnitine administration on ventilatory breakpoint and train efficiency throughout incremental train. J.Mazandaran Univ.Med.Sci. 2009;19(73):43-50.

Kavukcu, S., Turkmen, M., Salman, S., Onvural, B., Oktay, G., Karaman, O., and Cevik, N. T. The consequences of L-carnitine on respiratory operate checks in youngsters present process power hemodialysis. Turk.J Pediatr 1998;40(1):79-84. View summary.

Kimmoun, A., Munagamage, G., Dessalles, N., Gerard, A., Feillet, F., and Levy, B. Surprising awakening from comatose thyroid storm after a single intravenous injection of L-carnitine. Intensive Care Med. 2011;37(10):1716-1717. View summary.

Kobayashi, A., Masumura, Y., and Yamazaki, N. L-carnitine remedy for congestive coronary heart failure–experimental and medical research. Jpn Circ.J 1992;56(1):86-94. View summary.

Kobulia B, Chapichadze Z Andriadze G Machavariani P. Results of carnitine on 6-month incidence of mortality and coronary heart failure in sufferers with acute myocardial infarction. Ann Biomed Res Educ. 2002;2(3):240-243.

Kolker, S., Christensen, E., Leonard, J. V., Greenberg, C. R., Burlina, A. B., Burlina, A. P., Dixon, M., Duran, M., Goodman, S. I., Koeller, D. M., Muller, E., Naughten, E. R., Neumaier-Probst, E., Okun, J. G., Kyllerman, M., Surtees, R. A., Wilcken, B., Hoffmann, G. F., and Burgard, P. Guideline for the analysis and administration of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria sort I). J Inherit.Metab Dis 2007;30(1):5-22. View summary.

Kolker, S., Garbade, S. F., Greenberg, C. R., Leonard, J. V., Saudubray, J. M., Ribes, A., Kalkanoglu, H. S., Lund, A. M., Merinero, B., Wajner, M., Troncoso, M., Williams, M., Walter, J. H., Campistol, J., Marti-Herrero, M., Caswill, M., Burlina, A. B., Lagler, F., Maier, E. M., Schwahn, B., Tokatli, A., Dursun, A., Coskun, T., Chalmers, R. A., Koeller, D. M., Zschocke, J., Christensen, E., Burgard, P., and Hoffmann, G. F. Pure historical past, consequence, and remedy efficacy in youngsters and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr.Res. 2006;59(6):840-847. View summary.

Kosolcharoen T, Nappi J, Peduzzi P, and et al. Improved excercise tolerance after administration of carnitine. Present Therapeutic Analysis 1981;30(5):753-764.

Kotby, A. A., Yamamah, G. A. E., El-Baky, A. M. N. E. A., El-Kassas, G. M., and Elhalim, A. Z. A. Therapeutic analysis of L-carnitine in Egyptian youngsters with dilated cardiomyopathy. J.Med.Sci.(Pakistan) 2006;6(5):800-805.

Kraft, M., Kraft, Okay., Gartner, S., Mayerle, J., Simon, P., Weber, E., Schutte, Okay., Stieler, J., Koula-Jenik, H., Holzhauer, P., Grober, U., Engel, G., Muller, C., Feng, Y. S., Aghdassi, A., Nitsche, C., Malfertheiner, P., Patrzyk, M., Kohlmann, T., and Lerch, M. M. L-Carnitine-supplementation in superior pancreatic most cancers (CARPAN)–a randomized multicentre trial. Nutr J 2012;11:52. View summary.

Kumar, A., Singh, R. B., Saxena, M., Niaz, M. A., Josh, S. R., Chattopadhyay, P., Mechirova, V., Pella, D., and Fedacko, J. Impact of carni Q-gel (ubiquinol and carnitine) on cytokines in sufferers with coronary heart failure within the Tishcon research. Acta Cardiol. 2007;62(4):349-354. View summary.

Kumar, R., Gautam, G., and Gupta, N. P. Drug remedy for idiopathic male infertility: rationale versus proof. J Urol. 2006;176(4 Pt 1):1307-1312. View summary.

La, Vignera S., Condorelli, R., Vicari, E., D’Agata, R., and Calogero, A. E. Endothelial antioxidant compound extended the endothelial antiapoptotic results registered after tadalafil remedy in sufferers with arterial erectile dysfunction. J Androl 2012;33(2):170-175. View summary.

Labonia, W. D. L-carnitine results on anemia in hemodialyzed sufferers handled with erythropoietin. Am J Kidney Dis 1995;26(5):757-764. View summary.

Lacour, B., Di Giulio, S., Chanard, J., Ciancioni, C., Haguet, M., Lebkiri, B., Basile, C., Drueke, T., Assan, R., and Funck-Brentano, J. L. Carnitine improves lipid anomalies in haemodialysis sufferers. Lancet 10-11-1980;2(8198):763-764. View summary.

Laforet, P. and Vianey-Saban, C. Problems of muscle lipid metabolism: diagnostic and therapeutic challenges. Neuromuscul.Disord. 2010;20(11):693-700. View summary.

Lagioia, R., Scrutinio, D., Mangini, S. G., Ricci, A., Mastropasqua, F., Valentini, G., Ramunni, G., Totaro, Fila G., and Rizzon, P. Propionil-L-carnitine: a brand new compound within the metabolic strategy to the remedy of effort angina. Int J Cardiol 1992;34(2):167-172. View summary.

Lango, R., Smolenski, R. T., Rogowski, J., Siebert, J., Wujtewicz, M., Slominska, E. M., Lysiak-Szydlowska, W., and Yacoub, M. H. Propionyl-L-carnitine improves hemodynamics and metabolic markers of cardiac perfusion throughout coronary surgical procedure in diabetic sufferers. Cardiovasc.Medicine Ther 2005;19(4):267-275. View summary.

Larsson, L. E., Olegard, R., Ljung, B. M., Niklasson, A., Rubensson, A., and Cederblad, G. Parenteral vitamin in preterm neonates with and with out carnitine supplementation. Acta Anaesthesiol.Scand. 1990;34(6):501-505. View summary.

Le Tourneau, C., Faivre, S., Ciruelos, E., Dominguez, M. J., Lopez-Martin, J. A., Izquierdo, M. A., Jimeno, J., and Raymond, E. Stories of medical advantage of plitidepsin (Aplidine), a brand new marine-derived anticancer agent, in sufferers with superior medullary thyroid carcinoma. Am.J Clin Oncol. 2010;33(2):132-136. View summary.

Lee, M. S., Lee, H. J., Lee, H. S., and Kim, Y. L-carnitine stimulates lipolysis by way of induction of the lipolytic gene expression and suppression of the adipogenic gene expression in 3T3-L1 adipocytes. J Med.Meals 2006;9(4):468-473. View summary.

Lee, N. C., Tang, N. L., Chien, Y. H., Chen, C. A., Lin, S. J., Chiu, P. C., Huang, A. C., and Hwu, W. L. Diagnoses of newborns and moms with carnitine uptake defects via new child screening. Mol.Genet.Metab 2010;100(1):46-50. View summary.

Lee, P. J., Harrison, E. L., Jones, M. G., Jones, S., Leonard, J. V., and Chalmers, R. A. L-carnitine and train tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: a pilot research. J Inherit.Metab Dis. 2005;28(2):141-152. View summary.

Lenzi, A., Lombardo, F., Sgro, P., Salacone, P., Caponecchia, L., Dondero, F., and Gandini, L. Use of carnitine remedy in chosen circumstances of male issue infertility: a double-blind crossover trial. Fertil.Steril. 2003;79(2):292-300. View summary.

Li, B., Lloyd, M. L., Gudjonsson, H., Shug, A. L., and Olsen, W. A. The impact of enteral carnitine administration in people. Am J Clin Nutr 1992;55(4):838-845. View summary.

Li, Z., Chen, G. W., Shang, X. J., Bai, W. J., Han, Y. F., Chen, B., Teng, X. M., Meng, F. H., Zhang, B., Chen, D. N., Liu, J. H., Zheng, X. M., Cao, X. R., Liu, Y., Zhu, X. B., and Wang, Y. X. A managed randomized trial of using mixed L-carnitine and acetyl-L-carnitine remedy in males with oligoasthenozoospermia. Nat.J.Andro.(Chinese language) 2005;11:761-764.

Li, Z., Gu, R. H., Liu, Y., Xiang, Z. Q., Cao, X. R., Han, Y. F., Zhang, X. S., and Wang, Y. X. Healing impact of L-carnitine supplementation within the remedy of male infertility. Educational J.Shanghai Second Med.Univ. 2005;25:292-294.

Liammongkolkul, S., Kuptanon, C., Wasant, P., Vatanavicharn, N., Sawangareetrakul, P., Keeratichamroen, S., Cairns, J. R. Okay., Srisomsap, C., and Svasti, J. Novel mutation of methylmalonyl-CoA mutase gene in a Thai toddler with methylmalonic acidemia (mut0). Siriraj Med.J. 2009;61(4):215-217.

Liang, W. C., Ohkuma, A., Hayashi, Y. Okay., Lopez, L. C., Hirano, M., Nonaka, I., Noguchi, S., Chen, L. H., Jong, Y. J., and Nishino, I. ETFDH mutations, CoQ10 ranges, and respiratory chain actions in sufferers with riboflavin-responsive a number of acyl-CoA dehydrogenase deficiency. Neuromuscul.Disord. 2009;19(3):212-216. View summary.

Lim, C. Y., Jun, D. W., Jang, S. S., Cho, W. Okay., Chae, J. D., and Jun, J. H. Results of carnitine on peripheral blood mitochondrial DNA copy quantity and liver operate in non-alcoholic fatty liver illness. Korean J Gastroenterol. 2010;55(6):384-389. View summary.

Liu, S., Wu, H. J., Zhang, Z. Q., Chen, Q., Liu, B., Wu, J. P., and Zhu, L. L-carnitine ameliorates most cancers cachexia in mice by regulating the expression and exercise of carnitine palmityl transferase. Most cancers Biol.Ther 7-15-2011;12(2):125-130. View summary.

Loffredo, L., Marcoccia, A., Pignatelli, P., Andreozzi, P., Borgia, M. C., Cangemi, R., Chiarotti, F., and Violi, F. Oxidative-stress-mediated arterial dysfunction in sufferers with peripheral arterial illness. Eur.Coronary heart J 2007;28(5):608-612. View summary.

Loffredo, L., Pignatelli, P., Cangemi, R., Andreozzi, P., Panico, M. A., Meloni, V., and Violi, F. Imbalance between nitric oxide technology and oxidative stress in sufferers with peripheral arterial illness: impact of an antioxidant remedy. J Vasc.Surg. 2006;44(3):525-530. View summary.

Loumbakis P, Anezinis P, Evangeliou A, and et al. Impact of L-carnitine in sufferers with asthenospermia. Eur J Urol 1996;30(Suppl 2):954.

Lu, S. M., Li, X., Zhang, H. B., Hu, J. M., Yan, J. H., Liu, J. L., and Chen, Z. J. [Use of L-carnitine before percutaneous epididymal sperm aspiration-intracytoplasmic sperm injection for obstructive azoospermia]. Zhonghua Nan.Ke.Xue. 2010;16(10):919-921. View summary.

Lund, A. M., Joensen, F., Hougaard, D. M., Jensen, L. Okay., Christensen, E., Christensen, M., Norgaard-Petersen, B., Schwartz, M., and Skovby, F. Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe Islands. J Inherit.Metab Dis 2007;30(3):341-349. View summary.

Lynch, Okay. E., Feldman, H. I., Berlin, J. A., Flory, J., Rowan, C. G., and Brunelli, S. M. Results of L-carnitine on dialysis-related hypotension and muscle cramps: a meta-analysis. Am.J Kidney Dis 2008;52(5):962-971. View summary.

Ma, S. J., Cai, W. W., and Sheng, J. The consequences of anti-anxiety and despair remedy on life high quality of affected person with coronary coronary heart illness. Chinese language J.Clin.Healthcare 2008;11(5):478-480.

Ma, Y. Y., Tune, J. Q., Wu, T. F., Liu, Y. P., Xiao, J. X., Jiang, Y. W., and Yang, Y. L. [Leucodystrophy induced by late onset 3-hydroxy-3-methylglutaric aciduria]. Zhongguo Dang.Dai Er.Ke.Za Zhi. 2011;13(5):392-395. View summary.

Maccio, A., Madeddu, C., Gramignano, G., Mulas, C., Floris, C., Sanna, E., Cau, M. C., Panzone, F., and Mantovani, G. A randomized part III medical trial of a mixed remedy for cachexia in sufferers with gynecological cancers: evaluating the influence on metabolic and inflammatory profiles and high quality of life. Gynecol.Oncol 2012;124(3):417-425. View summary.

Madeddu, C., Dessi, M., Panzone, F., Serpe, R., Antoni, G., Cau, M. C., Montaldo, L., Mela, Q., Mura, M., Astara, G., Tanca, F. M., Maccio, A., and Mantovani, G. Randomized part III medical trial of a mixed remedy with carnitine + celecoxib +/- megestrol acetate for sufferers with cancer-related anorexia/cachexia syndrome. Clin Nutr 2012;31(2):176-182. View summary.

Maebashi, M., Kawamura, N., Sato, M., Imamura, A., and Yoshinaga, Okay. Lipid-lowering impact of carnitine in sufferers with type-IV hyperlipoproteinaemia. Lancet 10-14-1978;2(8094):805-807. View summary.

Maestri, A., De Pasquale, Ceratti A., Cundari, S., Zanna, C., Cortesi, E., and Crino, L. A pilot research on the impact of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy. Tumori 2005;91(2):135-138. View summary.

Maggi GC, Lomanto B, and Mazzola, C. Double-blind multicenter medical trial on the efficacy of phosphocreatinine vs L-carnitine and placebo in a bunch of sufferers affected by coronary heart illness. Acta Toxicol Ther 1990;11(2):173-184.

Maillart, E., Acquaviva-Bourdain, C., Rigal, O., Brivet, M., Jardel, C., Lombes, A., Eymard, B., Vianey-Saban, C., and Laforet, P. [Multiple acyl-CoA dehydrogenase deficiency (MADD): a curable cause of genetic muscular lipidosis]. Rev.Neurol.(Paris) 2010;166(3):289-294. View summary.

Malaguarnera, M., Bella, R., Vacante, M., Giordano, M., Malaguarnera, G., Gargante, M. P., Motta, M., Mistretta, A., Rampello, L., and Pennisi, G. Acetyl-L-carnitine reduces despair and improves high quality of life in sufferers with minimal hepatic encephalopathy. Scand.J Gastroenterol. 2011;46(6):750-759. View summary.

Malaguarnera, M., Gargante, M. P., Cristaldi, E., Colonna, V., Messano, M., Koverech, A., Neri, S., Vacante, M., Cammalleri, L., and Motta, M. Acetyl L-carnitine (ALC) remedy in aged sufferers with fatigue. Arch.Gerontol.Geriatr. 2008;46(2):181-190. View summary.

Malaguarnera, M., Gargante, M. P., Cristaldi, E., Vacante, M., Risino, C., Cammalleri, L., Pennisi, G., and Rampello, L. Acetyl-L-carnitine remedy in minimal hepatic encephalopathy. Dig.Dis Sci 2008;53(11):3018-3025. View summary.

Malaguarnera, M., Gargante, M. P., Russo, C., Antic, T., Vacante, M., Malaguarnera, M., Avitabile, T., Li, Volti G., and Galvano, F. L-carnitine supplementation to food plan: a brand new device in remedy of nonalcoholic steatohepatitis–a randomized and managed medical trial. Am.J Gastroenterol. 2010;105(6):1338-1345. View summary.

Malaguarnera, M., Pistone, G., Astuto, M., Dell’Arte, S., Finocchiaro, G., Lo, Giudice E., and Pennisi, G. L-Carnitine within the remedy of delicate or reasonable hepatic encephalopathy. Dig.Dis. 2003;21(3):271-275. View summary.

Malaguarnera, M., Pistone, G., Astuto, M., Vecchio, I., Raffaele, R., Lo, Giudice E., and Rampello, L. Results of L-acetylcarnitine on cirrhotic sufferers with hepatic coma: randomized double-blind, placebo-controlled trial. Dig.Dis Sci 2006;51(12):2242-2247. View summary.

Malaguarnera, M., Pistone, G., Elvira, R., Leotta, C., Scarpello, L., and Liborio, R. Results of L-carnitine in sufferers with hepatic encephalopathy. World J Gastroenterol. 12-7-2005;11(45):7197-7202. View summary.

Malaguarnera, M., Risino, C., Cammalleri, L., Malaguarnera, L., Astuto, M., Vecchio, I., and Rampello, L. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA remedy in hepatic coma: a randomized and managed double blind research. Eur.J Gastroenterol.Hepatol. 2009;21(7):762-770. View summary.

Malaguarnera, M., Vacante, M., Avitabile, T., Malaguarnera, M., Cammalleri, L., and Motta, M. L-Carnitine supplementation reduces oxidized LDL ldl cholesterol in sufferers with diabetes. Am J Clin.Nutr 2009;89(1):71-76. View summary.

Malaguarnera, M., Vacante, M., Bertino, G., Neri, S., Malaguarnera, M., Gargante, M. P., Motta, M., Lupo, L., Chisari, G., Bruno, C. M., Pennisi, G., and Bella, R. The supplementation of acetyl-L-carnitine decreases fatigue and will increase high quality of life in sufferers with hepatitis C handled with pegylated interferon-alpha 2b plus ribavirin. J Interferon Cytokine Res 2011;31(9):653-659. View summary.

Malaguarnera, M., Vacante, M., Giordano, M., Motta, M., Bertino, G., Pennisi, M., Neri, S., Malaguarnera, M., Li, Volti G., and Galvano, F. L-carnitine supplementation improves hematological sample in sufferers affected by HCV handled with Peg interferon-alpha 2b plus ribavirin. World J Gastroenterol. 10-21-2011;17(39):4414-4420. View summary.

Malaguarnera, M., Vacante, M., Giordano, M., Pennisi, G., Bella, R., Rampello, L., Malaguarnera, M., Li, Volti G., and Galvano, F. Oral acetyl-L-carnitine remedy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled research. Am.J Clin Nutr. 2011;93(4):799-808. View summary.

Malaguarnera, M., Vacante, M., Motta, M., Giordano, M., Malaguarnera, G., Bella, R., Nunnari, G., Rampello, L., and Pennisi, G. Acetyl-L-carnitine improves cognitive capabilities in extreme hepatic encephalopathy: a randomized and managed medical trial. Metab Mind Dis 2011;26(4):281-289. View summary.

Malaguarnera, M., Vacante, M., Motta, M., Malaguarnera, M., Li, Volti G., and Galvano, F. Impact of L-carnitine on the scale of low-density lipoprotein particles in sort 2 diabetes mellitus sufferers handled with simvastatin. Metabolism 2009;58(11):1618-1623. View summary.

Malone, M. A., Schocken, D. D., Hanna, S. Okay., Liang, X., and Malone, J. I. Diabetes-induced bradycardia is an intrinsic metabolic defect reversed by carnitine. Metabolism 2007;56(8):1118-1123. View summary.

Malvagia, S., Papi, L., Morrone, A., Donati, M. A., Ciani, F., Pasquini, E., la, Marca G., Scholte, H. R., Genuardi, M., and Zammarchi, E. Deadly malonyl CoA decarboxylase deficiency on account of maternal uniparental isodisomy of the telomeric finish of chromosome 16. Ann.Hum.Genet. 2007;71(Pt 6):705-712. View summary.

Mantero MA, Barbero M, Giannini R, and et al. Acetyl-L-carnitine as a therapeutic agent for psychological deterioration in geriatric sufferers (Double-blind placebo managed research). New Tendencies Clin Neuropharmacol 1989;3(1):17-24.

Mantovani, G. Randomised part III medical trial of 5 completely different arms of remedy on 332 sufferers with most cancers cachexia. Eur.Rev.Med.Pharmacol Sci 2010;14(4):292-301. View summary.

Mantovani, G., Maccio, A., Madeddu, C., Gramignano, G., Serpe, R., Massa, E., Dessi, M., Tanca, F. M., Sanna, E., Deiana, L., Panzone, F., Contu, P., and Floris, C. Randomized part III medical trial of 5 completely different arms of remedy for sufferers with most cancers cachexia: interim outcomes. Diet 2008;24(4):305-313. View summary.

Mantovani, G., Maccio, A., Madeddu, C., Serpe, R., Massa, E., Dessi, M., Panzone, F., and Contu, P. Randomized part III medical trial of 5 completely different arms of remedy in 332 sufferers with most cancers cachexia. Oncologist. 2010;15(2):200-211. View summary.

Marti-Carvajal, A. J., Knight-Madden, J. M., and Martinez-Zapata, M. J. Interventions for treating leg ulcers in folks with sickle cell illness. Cochrane.Database.Syst.Rev. 2012;11:CD008394. View summary.

Martina, B., Zuber, M., Weiss, P., Burkart, F., and Ritz, R. [Anti-arrhythmia treatment using L-carnitine in acute myocardial infarct]. Schweiz.Med Wochenschr 9-12-1992;122(37):1352-1355. View summary.

Martinotti, G., Andreoli, S., Reina, D., Di, Nicola M., Ortolani, I., Tedeschi, D., Fanella, F., Pozzi, G., Iannoni, E., D’Iddio, S., and Prof, L. J. Acetyl-l-Carnitine within the remedy of anhedonia, melancholic and damaging signs in alcohol dependent topics. Prog.Neuropsychopharmacol.Biol.Psychiatry 6-1-2011;35(4):953-958. View summary.

Martinotti, G., Reina, D., Di, Nicola M., Andreoli, S., Tedeschi, D., Ortolani, I., Pozzi, G., Iannoni, E., D’Iddio, S., and Janiri, L. Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trial. Alcohol Alcohol 2010;45(5):449-455. View summary.

Mate, A., Miguel-Carrasco, J. L., Monserrat, M. T., and Vazquez, C. M. Systemic antioxidant properties of L-carnitine in two completely different fashions of arterial hypertension. J Physiol Biochem. 2010;66(2):127-136. View summary.

McMackin, C. J., Widlansky, M. E., Hamburg, N. M., Huang, A. L., Weller, S., Holbrook, M., Gokce, N., Hagen, T. M., Keaney, J. F., Jr., and Vita, J. A. Impact of mixed remedy with alpha-Lipoic acid and acetyl-L-carnitine on vascular operate and blood stress in sufferers with coronary artery illness. J Clin Hypertens.(Greenwich.) 2007;9(4):249-255. View summary.

Megri Okay, Trombert JC Zannier A. Impact de la L-carnitine chez les sufferers en hemodialyse chronique traite e par erythropoietine recombinante [abstract]. Nephrologie 1998;19:171.

Melegh, B., Kerner, J., Sandor, A., Vinceller, M., and Kispal, G. Results of oral L-carnitine supplementation in low-birth-weight untimely infants maintained on human milk. Biol.Neonate 1987;51(4):185-193. View summary.

Mercadal, L., Coudert, M., Vassault, A., Pieroni, L., Debure, A., Ouziala, M., Depreneuf, H., Fumeron, C., Servais, A., Bassilios, N., Becart, J., Assogba, U., Allouache, M., Bouali, B., Luong, N., Dousseaux, M. P., Tezenas-du, Montcel S., and Deray, G. L-carnitine remedy in incident hemodialysis sufferers: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial. Clin J Am Soc Nephrol. 2012;7(11):1836-1842. View summary.

Service provider, R., Jain, A., Udani, A., Puri, V., and Kotian, M. L-carnitine in beta thalassemia. Indian Pediatr. 2010;47(2):165-167. View summary.

Mettang, T., Thomas, S., and Kuhlmann, U. L-carnitine doesn’t alleviate uremic pruritus in hemodialysis sufferers. Nephron 1997;75(3):372. View summary.

Miguel-Carrasco, J. L., Mate, A., Monserrat, M. T., Arias, J. L., Aramburu, O., and Vazquez, C. M. The function of inflammatory markers within the cardioprotective impact of L-carnitine in L-NAME-induced hypertension. Am.J Hypertens. 2008;21(11):1231-1237. View summary.

Mikhailova, T. L., Sishkova, E., Poniewierka, E., Zhidkov, Okay. P., Bakulin, I. G., Kupcinskas, L., Lesniakowski, Okay., Grinevich, V. B., Malecka-Panas, E., Ardizzone, S., D’Arienzo, A., Valpiani, D., Koch, M., Denapiene, G., Vago, G., Fociani, P., Zerbi, P., Ceracchi, M., Camerini, R., and Gasbarrini, G. Randomised medical trial: the efficacy and security of propionyl-L-carnitine remedy in sufferers with ulcerative colitis receiving steady oral remedy. Aliment.Pharmacol Ther 2011;34(9):1088-1097. View summary.

Milazzo, L., Menzaghi, B., Caramma, I., Nasi, M., Sangaletti, O., Cesari, M., Zanone, Poma B., Cossarizza, A., Antinori, S., and Galli, M. Impact of antioxidants on mitochondrial operate in HIV-1-related lipoatrophy: a pilot research. AIDS Res.Hum.Retroviruses 2010;26(11):1207-1214. View summary.

Miles, C. L., Sweet, B., Jones, L., Williams, R., Tookman, A., and King, M. Interventions for sexual dysfunction following therapies for most cancers. Cochrane.Database.Syst.Rev. 2007;(4):CD005540. View summary.

Milio, G., Novo, G., Genova, C., Luigi, Almasio P., Novo, S., and Pinto, A. Pharmacological remedy of sufferers with power important limb ischemia: L-propionyl-carnitine enhances the short-term results of PGE-1. Cardiovasc.Medicine Ther 2009;23(4):301-306. View summary.

Mioli V, Tarchini R, Boggi R, and et al. Use of D,L- and L-carnitine in uraemic sufferers on intermittent haemodialysis. Int J Clin Pharm Res 1982;2(2):143-148.

Mitwalli A, Wakeel J Alam A Tarif N Abu-Afsha A. The impact of L-carnitine complement on dialysis sufferers [abstract]. 1999;

Mitwalli, A. H., Al-Wakeel, J. S., Alam, A., Tarif, N., Abu-Aisha, H., Rashed, M., and Al, Nahed N. L-carnitine supplementation in hemodialysis sufferers. Saudi.J Kidney Dis Transpl. 2005;16(1):17-22. View summary.

Miwa, S. and Takikawa, O. [Chronic fatigue syndrome and neurotransmitters]. Nihon Rinsho 2007;65(6):1005-1010. View summary.

Molfino, A., Cascino, A., Conte, C., Ramaccini, C., Rossi, Fanelli F., and Laviano, A. Caloric restriction and L-carnitine administration improves insulin sensitivity in sufferers with impaired glucose metabolism. JPEN J Parenter.Enteral Nutr. 2010;34(3):295-299. View summary.

Molyneux, R., Seymour, A. M., and Bhandari, S. Worth of carnitine remedy in kidney dialysis sufferers and results on cardiac operate from human and animal research. Curr Drug Targets. 2012;13(2):285-293. View summary.

Mondillo, S., Faglia, S., D’Aprile, N., Mangiacotti, L., Campolo, M. A., Agricola, E., and Palazzuoli, V. [Therapy of arrhythmia induced by myocardial ischemia. Association of L- carnitine, propafenone and mexiletine]. Clin Ter. 1995;146(12):769-774. View summary.

Moradi, M., Moradi, A., Alemi, M., Ahmadnia, H., Abdi, H., Ahmadi, A., and Bazargan-Hejazi, S. Security and efficacy of clomiphene citrate and L-carnitine in idiopathic male infertility: a comparative research. Urol.J 2010;7(3):188-193. View summary.

Morano, S., Mandosi, E., Fallarino, M., Gatti, A., Tiberti, C., Sensi, M., Gandini, L., Buchetti, B., Lenti, L., Jannini, E. A., and Lenzi, A. Antioxidant remedy related to sildenafil reduces monocyte activation and markers of endothelial injury in sufferers with diabetic erectile dysfunction: a double-blind, placebo-controlled research. Eur.Urol. 2007;52(6):1768-1774. View summary.

Morgante, G., Scolaro, V., Tosti, C., Di, Sabatino A., Piomboni, P., and De, Leo, V. [Treatment with carnitine, acetyl carnitine, L-arginine and ginseng improves sperm motility and sexual health in men with asthenopermia]. Minerva Urol.Nefrol. 2010;62(3):213-218. View summary.

Moustafa, A. M. and Boshra, V. The doable function of L-carnitine on the skeletal muscle of ovariectomized rats. J Mol.Histol. 2011;42(3):217-225. View summary.

Muniyappa, R. Oral carnitine remedy and insulin resistance. Hypertension 2010;55(2):e13. View summary.

Musso, G., Gambino, R., Cassader, M., and Pagano, G. A meta-analysis of randomized trials for the remedy of nonalcoholic fatty liver illness. Hepatology 2010;52(1):79-104. View summary.

Nagai, N., Kameda, N., Kobashi, R., Nishida, M., Horikawa, C., Egawa, Okay., Yoshimura, M., Kitagawa, Y., Abe, Okay., Kiso, Y., Sakane, N., Kotani, Okay., and Moritani, T. Impact of L-carnitine consumption upon discount of starvation feeling in younger wholesome females. J.Japanese Society Diet Meals Sci 2007;60(5):257-264.

Nasca D, Zurria G, and Aguglia E. Motion of acetyl-L-carnitine in affiliation with mianserine on depressed outdated folks. New Tendencies Clin Neuropharmacol 1989;3(4):225-230.

Nasser, M., Javaheri, H., Fedorowicz, Z., and Noorani, Z. Carnitine supplementation for inborn errors of metabolism. Cochrane.Database.Syst.Rev. 2009;(2):CD006659. View summary.

Nasser, M., Javaheri, H., Fedorowicz, Z., and Noorani, Z. Carnitine supplementation for inborn errors of metabolism. Cochrane.Database.Syst.Rev. 2012;2:CD006659. View summary.

Nikolaos, S., George, A., Telemachos, T., Maria, S., Yannis, M., and Konstantinos, M. Impact of L-carnitine supplementation on purple blood cells deformability in hemodialysis sufferers. Ren Fail. 2000;22(1):73-80. View summary.

Nilsson-Ehle, P., Cederblad, G., Fagher, B., Monti, M., and Thysell, H. Plasma lipoproteins, liver operate and glucose metabolism in haemodialysis sufferers: lack of impact of L-carnitine supplementation. Scand.J Clin Lab Make investments 1985;45(2):179-184. View summary.

Nourshahi, M., Kaviani, M., Kimiagar, M., and Ebrahim, Okay. H. The consequences of acute L-carnitine supplementation on anaerobic threshold and lactate accumulation throughout an incremental train. Iranian J.Nutr.Sci.Meals Technol. 2009;4(27):45-52.

Nourshahi, M., Rajaeyan, A., Kimiagar, M., and Ebrahim, Okay. The consequences of L-carnitine supplementation in numerous phases of menstrual cycle on the metabolic responses after exhausted train in lively girls. Iranian J.Nutr.Sci.Meals Technol. 2011;6(1):23-32.

Novak M, Monkus EF, Buch M, and et al. L-carnitine supplementation of a soybean-based formulation in early infancy: plasma and urine ranges of carnitine and acylcarnitines. J Pediatr Gastroenterol Nutr 1987;7:220-224.

O’Brien, D., Chunduri, P., Iyer, A., and Brown, L. L-carnitine attenuates cardiac remodelling quite than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats. Fundamental Clin Pharmacol Toxicol. 2010;106(4):296-301. View summary.

O’Donnell, J., Finer, N. N., Wealthy, W., Barshop, B. A., and Barrington, Okay. J. Function of L-carnitine in apnea of prematurity: a randomized, managed trial. Pediatrics 2002;109(4):622-626. View summary.

Orlandi, A., Francesconi, A., Ferlosio, A., Di, Lascio A., Marcellini, M., Pisano, C., and Spagnoli, L. G. Propionyl-L-carnitine prevents age-related myocardial reworking within the rabbit. J Cardiovasc.Pharmacol 2007;50(2):168-175. View summary.

Orlando G and Rusconi C. Oral L-carnitine within the remedy of power cardiac ischaemia in aged sufferers. Medical Trials Journal 1986;23(6):338-344.

Pacheco, A., Torres, R., Sanhueza, M. E., Elgueta, L., Segovia, E., and Cano, M. [Study of aerobic capacity in chronic hemodialized patients: effect of L-carnitine supplementation]. Med.Clin (Barc.) 4-5-2008;130(12):441-445. View summary.

Palazzuoli, V., Mondillo, S., Faglia, S., D’Aprile, N., Camporeale, A., and Gennari, C. [The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy]. Clin Ter. 1993;142(2):155-159. View summary.

Pande, S., Brion, L. P., Campbell, D. E., Gayle, Y., and Esteban-Cruciani, N. V. Lack of impact of L-carnitine supplementation on weight acquire in very preterm infants. J Perinatol. 2005;25(7):470-477. View summary.

Panjwani, U., Thakur, L., Anand, J. P., Singh, S. N., Amitabh, Singh, S. B., and Banerjee, P. Okay. Impact of L-carnitine supplementation on endurance train in normobaric/normoxic and hypobaric/hypoxic situations. Wilderness.Environ.Med. 2007;18(3):169-176. View summary.

Park, H. D., Kim, S. R., Ki, C. S., Lee, S. Y., Chang, Y. S., Jin, D. Okay., and Park, W. S. Two novel HADHB gene mutations in a Korean affected person with mitochondrial trifunctional protein deficiency. Ann.Clin Lab Sci 2009;39(4):399-404. View summary.

Passeri, M., Iannuccelli, M., Ciotti, G., Bonati, P. A., Nolfe, G., and Cucinotta, D. Psychological impairment in getting older: collection of sufferers, strategies of analysis and therapeutic potentialities of acetyl-L-carnitine. Int J Clin Pharmacol Res 1988;8(5):367-376. View summary.

Pastoris, O., Dossena, M., Foppa, P., Catapano, M., Arbustini, E., Bellini, O., Dal Bello, B., Minzioni, G., Ceriana, P., and Barzaghi, N. Impact of L-carnitine on myocardial metabolism: outcomes of a balanced, placebo-controlled, double-blind research in sufferers present process open coronary heart surgical procedure. Pharmacol Res 1998;37(2):115-122. View summary.

Patrikarea A, Stamatelow Okay Ntaountaki I Papadakis IT. The impact of mixed L-carnitine and erythropoietin administration on the anaemia and on the lipid profile of sufferers on hemodialysis [abstract]. Nephrol Dial Transplant 1996;11:A262.

Payne, C., Wiffen, P. J., and Martin, S. Interventions for fatigue and weight reduction in adults with superior progressive sickness. Cochrane.Database.Syst.Rev. 2012;1:CD008427. [RETRACTED]. View summary.

Pehlivanoglu S, Enar R Mutlu H Sert A Ersalni M Yazicioglu N. The impact of L-carnitine on left ventricular operate in sufferers with acute myocardial infarction handled with streptokinase. Türk Kardiyol Dern Ars ¸-Arch Turk Soc Cardiol. 1996;24(4):251-255.

Peivandi, S., Karimpour, A., and Moslemizadeh, N. Results of L-carnitine on infertile males’s spermogram; a randomized medical trial. J.Reprod.Infertil 2010;10(4):245-251.

Penn, D., Schmidt-Sommerfeld, E., and Pascu, F. Decreased tissue carnitine concentrations in new child infants receiving whole parenteral vitamin. J Pediatr 1981;98(6):976-978. View summary.

Penn, D., Schmidt-Sommerfeld, E., and Wolf, H. Carnitine deficiency in untimely infants receiving whole parenteral vitamin. Early Hum.Dev. 1980;4(1):23-34. View summary.

Perez-Oliva, J. F., Guillen, Y., Gutierrez, F., and Parodis, Y. [Reduction of hospitalization thanks to L-carnitine in hemodialyzed patients]. Nefrologia. 2006;26(4):499-500. View summary.

Perna, A. F., Acanfora, F., Satta, E., Lombardi, C., Capasso, R., Ingrosso, D., and De Santo, N. G. L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis. J Nephrol. 2007;20(1):63-65. View summary.

Perrott, J., Murphy, N. G., and Zed, P. J. L-carnitine for acute valproic acid overdose: a scientific assessment of printed circumstances. Ann.Pharmacother. 2010;44(7-8):1287-1293. View summary.

Pesce, V., Fracasso, F., Cassano, P., Lezza, A. M., Cantatore, P., and Gadaleta, M. N. Acetyl-L-carnitine supplementation to outdated rats partially reverts the age-related mitochondrial decay of soleus muscle by activating peroxisome proliferator-activated receptor gamma coactivator-1alpha-dependent mitochondrial biogenesis. Rejuvenation.Res. 2010;13(2-3):148-151. View summary.

Pettegrew, J. W., Levine, J., Gershon, S., Stanley, J. A., Servan-Schreiber, D., Panchalingam, Okay., and McClure, R. J. 31P-MRS research of acetyl-L-carnitine remedy in geriatric despair: preliminary outcomes. Bipolar.Disord. 2002;4(1):61-66. View summary.

Phillips, T. J., Cherry, C. L., Cox, S., Marshall, S. J., and Rice, A. S. Pharmacological remedy of painful HIV-associated sensory neuropathy: a scientific assessment and meta-analysis of randomised managed trials. PLoS.One. 2010;5(12):e14433. View summary.

Pichard, C., Roulet, M., Rossle, C., Chiolero, R., Schutz, Y., Temler, E., Boumghar, M., Schindler, C., Zurlo, F., Jequier, E., and . Results of L-carnitine supplemented whole parenteral vitamin on lipid and vitality metabolism in postoperative stress. JPEN J Parenter.Enteral Nutr 1988;12(6):555-562. View summary.

Pichard, C., Roulet, M., Schutz, Y., Rossle, C., Chiolero, R., Temler, E., Schindler, C., Zurlo, F., Furst, P., and Jequier, E. Medical relevance of L-carnitine-supplemented whole parenteral vitamin in postoperative trauma. Metabolic results of steady or acute carnitine administration with particular reference to fats oxidation and nitrogen utilization. Am J Clin Nutr 1989;49(2):283-289. View summary.

Pickard, R. Editorial touch upon: Antioxidant remedy related to sildenafil reduces monocyte activation and markers of endothelial injury in sufferers with diabetic erectile dysfunction: a double-blind, placebo-controlled research. Eur.Urol. 2007;52(6):1774-1775. View summary.

Pietropaoli, P., Caporelli, S., De Tempo, F., Donati, A., Adrario, E., Luzi, A., Munch, C., Giovannini, C., and Frezzotti, A. R. [Intraoperative lactic acidosis, can it be treated? Clinico- experimental, prospective, sequential study]. Minerva Anestesiol. 1994;60(12):707-713. View summary.

Pignatelli, P., Tellan, G., Marandola, M., Carnevale, R., Loffredo, L., Schillizzi, M., Proietti, M., Violi, F., Chirletti, P., and Delogu, G. Impact of L-carnitine on oxidative stress and platelet activation after main surgical procedure. Acta Anaesthesiol.Scand. 2011;55(8):1022-1028. View summary.

Pittler, M. H. and Ernst, E. Complementary therapies for neuropathic and neuralgic ache: systematic assessment. Clin J Ache 2008;24(8):731-733. View summary.

Plochl, E., Sperl, W., Wermuth, B., and Colombo, J. P. [Carnitine deficiency and carnitine therapy in a patient with Rett syndrome]. Klin Padiatr. 1996;208(3):129-134. View summary.

Pola P, Savi M, Grilli M, and et al. Carnitine within the remedy of dyslipidemic sufferers. Curr Ther Res 1980;27(2):208-216.

Pola P, Tondi P, Dal Lago A, and et al. Statistical analysis of long-term L-carnitine remedy in hyperlipoproteinaemias. Medicine Exper Clin Res 1983;9:925-934.

Pola, P., Tondi, P., Flore, R., Serricchio, M., Dal Lago, A., Amanti, C., Consorti, F., Benedetti, M., and Midiri, H. Impact of l-carnitine on lipid sample in debilitated sufferers handled with Intralipid. Int J Clin Pharmacol Res 1983;3(3):179-184. View summary.

Pollard, L. M., Williams, N. R., Espinoza, L., Wooden, T. C., Spector, E. B., Schroer, R. J., and Holden, Okay. R. Prognosis, remedy, and long-term outcomes of late-onset (sort III) a number of acyl-CoA dehydrogenase deficiency. J Little one Neurol. 2010;25(8):954-960. View summary.

Porter, N. S., Jason, L. A., Boulton, A., Bothne, N., and Coleman, B. Different medical interventions used within the remedy and administration of myalgic encephalomyelitis/power fatigue syndrome and fibromyalgia. J.Altern.Complement Med. 2010;16(3):235-249. View summary.

Pryor, J. L., Glass, S. L., Campagnone, J., and Sigman, M. Randomized double blind placebo managed trial of carnitine for the remedy of idiopathic asthenospermia. Fertil.Steril 2003;80(Suppl 3):48.

Pucciarelli, G., Mastursi, M., Latte, S., Sacra, C., Setaro, A., Lizzadro, A., and Nolfe, G. [The clinical and hemodynamic effects of propionyl-L-carnitine in the treatment of congestive heart failure]. Clin Ter. 1992;141(11):379-384. View summary.

Pueschel, S. M. The impact of acetyl-L-carnitine administration on individuals with Down syndrome. Res.Dev.Disabil. 2006;27(6):599-604. View summary.

Pugliese, D., Sabba, C., Ettorre, G., Berardi, E., Antonica, G., Godi, L., Palasciano, G., Lee, S. S., and Albano, O. Acute systemic and splanchnic haemodynamic results of L-carnitine in sufferers with cirrhosis. Medicine Exp Clin Res 1992;18(4):147-153. View summary.

Quatraro, A., Roca, P., Donzella, C., Acampora, R., Marfella, R., and Giugliano, D. Acetyl-L-carnitine for symptomatic diabetic neuropathy. Diabetologia 1995;38(1):123. View summary.

Rahbar, A. R., Shakerhosseini, R., Saadat, N., Taleban, F., Pordal, A., and Gollestan, B. Impact of L-carnitine on plasma glycemic and lipidemic profile in sufferers with sort II diabetes mellitus. Eur.J Clin.Nutr. 2005;59(4):592-596. View summary.

Rajasekar, P. and Anuradha, C. V. Impact of L-carnitine on skeletal muscle lipids and oxidative stress in rats fed high-fructose food plan. Exp.Diabetes Res. 2007;2007:72741. View summary.

Rajasekar, P. and Anuradha, C. V. L-Carnitine inhibits protein glycation in vitro and in vivo: proof for a job in diabetic administration. Acta Diabetol. 2007;44(2):83-90. View summary.

Rajasekar, P., Palanisamy, N., and Anuradha, C. V. Improve in nitric oxide and reductions in blood stress, protein kinase C beta II and oxidative stress by L-carnitine: a research within the fructose-fed hypertensive rat. Clin Exp.Hypertens. 2007;29(8):517-530. View summary.

Rathod, R., Baig, M. S., Khandelwal, P. N., Kulkarni, S. G., Gade, P. R., and Siddiqui, S. Outcomes of a single blind, randomized, placebo-controlled medical trial to review the impact of intravenous L-carnitine supplementation on health-related high quality of life in Indian sufferers on upkeep hemodialysis. Indian J Med.Sci 2006;60(4):143-153. View summary.

Rebuzzi AG, Schiavani G, Amico C, and et al. Helpful results of L-carnitine within the discount of the necrotic space in acute myocardial infarction. Medicine Exp Clin Res 1984;10(4):219-223.

Remington, R., Chan, A., Paskavitz, J., and Shea, T. B. Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer’s illness: a placebo-controlled pilot research. Am.J Alzheimers.Dis Different Demen. 2009;24(1):27-33. View summary.

Reuter, S. E. and Evans, A. M. Lengthy-chain acylcarnitine deficiency in sufferers with power fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I exercise. J Intern.Med. 2011;270(1):76-84. View summary.

Ribas, G. S., Manfredini, V., de Mari, J. F., Wayhs, C. Y., Vanzin, C. S., Biancini, G. B., Sitta, A., Deon, M., Wajner, M., and Vargas, C. R. Discount of lipid and protein injury in sufferers with issues of propionate metabolism underneath remedy: a doable protecting function of L-carnitine supplementation. Int.J Dev.Neurosci. 2010;28(2):127-132. View summary.

Ricci, A., Caiati, C., Galantino, A., Scrutinio, D., Valentini, G., Chiddo, A., and Rizzon, P. [Acute effects of propionyl-L-carnitine on anomalies of parietal kinetics of the left ventricle induced by atrial pacing in patients with ischemic heart disease. A bidimensional echocardiographic study]. Cardiologia 1989;34(7):651-655. View summary.

Riccioni, C., Sarcinella, R., Izzo, A., Palermo, G., Liguori, M., Caliumi, C., Carloni, E., Paolucci, A. M., D’andrea, P., and Pompili, S. Rehabilitative remedy in peripheral artery illness: protocol utility and follow-up. Minerva Cardioangiol. 2010;58(5):551-565. View summary.

Riccioni, C., Sarcinella, R., Palermo, G., Izzo, A., Liguori, M., Koverech, A., Messano, M., and Virmani, A. Analysis of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic sufferers affected by obliterating arteriopathy Leriche stage II. Int.Angiol. 2008;27(3):253-259. View summary.

Rizzon, P., Biasco, G., Di Biase, M., Boscia, F., Rizzo, U., Minafra, F., Bortone, A., Siliprandi, N., Procopio, A., Bagiella, E., and . Excessive doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic results. Eur Coronary heart J 1989;10(6):502-508. View summary.

Rodriguez DR, endible A, Gomez N, and et al. Drug intervention program in dyslipemic youngsters: use of L-carnitine. Revista Latina De Cardiologia – Euroamericana 1997;18(2):25-30.

Rogerson, M. E., Rylance, P. B., Wilson, R., De Sousa, C., Lanigan, C., Rose, P. E., Howard, J., and Parsons, V. Carnitine and weak spot in haemodialysis sufferers. Nephrol Dial.Transplant. 1989;4(5):366-371. View summary.

Romano, M., Vacante, M., Cristaldi, E., Colonna, V., Gargante, M. P., Cammalleri, L., and Malaguarnera, M. L-carnitine remedy reduces steatosis in sufferers with power hepatitis C handled with alpha-interferon and ribavirin. Dig.Dis Sci 2008;53(4):1114-1121. View summary.

Ross, C., Morriss, A., Khairy, M., Khalaf, Y., Braude, P., Coomarasamy, A., and El-Toukhy, T. A scientific assessment of the impact of oral antioxidants on male infertility. Reprod.Biomed.On-line. 2010;20(6):711-723. View summary.

Rossignol, D. A. and Frye, R. E. Mitochondrial dysfunction in autism spectrum issues: a scientific assessment and meta-analysis. Mol.Psychiatry 2012;17(3):290-314. View summary.

Rossignol, D. A. Novel and rising therapies for autism spectrum issues: a scientific assessment. Ann.Clin Psychiatry 2009;21(4):213-236. View summary.

Rossini, D., Bulckaen, M., Di, Marco S., Giovannetti, R., Giuntoli, F., Lacopetti, L., and Vergoni, W. [Rehabilitation program in patients with moderate-to-severe intermittent claudication: immediate results and one year follow-up]. Monaldi Arch.Chest Dis 2007;68(2):110-114. View summary.

Rossini, M., Di, Munno O., Valentini, G., Bianchi, G., Biasi, G., Cacace, E., Malesci, D., La, Montagna G., Viapiana, O., and Adami, S. Double-blind, multicenter trial evaluating acetyl l-carnitine with placebo within the remedy of fibromyalgia sufferers. Clin Exp.Rheumatol. 2007;25(2):182-188. View summary.

Rossini, P. M., Marchionno, L., Gambi, D., Pirchio, M., Del Rosso, G., and Albertazzi, A. EMG adjustments in chronically dialyzed uraemic topics present process d, 1- Carnitine remedy. Ital J Neurol Sci 1981;2(3):255-262. View summary.

Rossle, C., Pichard, C., Roulet, M., Chiolero, R., Schutz, Y., Temler, E., Schindler, C., Zurlo, F., Jequier, E., and Furst, P. [Effect of L-carnitine supplemented total parenteral nutrition on postoperative lipid and nitrogen utilization]. Klin.Wochenschr 12-15-1988;66(24):1202-1211. View summary.

Roure, R., Oddos, T., Rossi, A., Vial, F., and Bertin, C. Analysis of the efficacy of a topical beauty slimming product combining tetrahydroxypropyl ethylenediamine, caffeine, carnitine, forskolin and retinol, In vitro, ex vivo and in vivo research. Int.J Cosmet.Sci 2011;33(6):519-526. View summary.

Roy, M. J., Dionne, S., Marx, G., Qureshi, I., Sarma, D., Levy, E., and Seidman, E. G. In vitro research on the inhibition of colon most cancers by butyrate and carnitine. Diet 2009;25(11-12):1193-1201. View summary.

Rueda, J. R., Ballesteros, J., and Tejada, M. I. Systematic assessment of pharmacological therapies in fragile X syndrome. BMC.Neurol. 2009;9:53. View summary.

Ruggenenti, P., Cattaneo, D., Loriga, G., Ledda, F., Motterlini, N., Gherardi, G., Orisio, S., and Remuzzi, G. Ameliorating hypertension and insulin resistance in topics at elevated cardiovascular threat: results of acetyl-L-carnitine remedy. Hypertension 2009;54(3):567-574. View summary.

Russell, S. Carnitine as an antidote for acute valproate toxicity in youngsters. Curr.Opin.Pediatr. 2007;19(2):206-210. View summary.

Sabba, C., Berardi, E., Antonica, G., Ferraioli, G., Buonamico, P., Godi, L., Brevetti, G., and Albano, O. Comparability between the impact of L-propionylcarnitine, L- acetylcarnitine and nitroglycerin in power peripheral arterial illness: a haemodynamic double blind echo-Doppler research. Eur Coronary heart J 1994;15(10):1348-1352. View summary.

Sabry, A. A. The function of oral L-carnitine remedy in power hemodialysis sufferers. Saudi.J Kidney Dis Transpl. 2010;21(3):454-459. View summary.

Sabry, A. A., Ghaith, O., Medhat, T., George, S. Okay., and Elshafey, E. M. Is there a job for oral L-carnitine remedy in anemia and cardiac dysfunction administration in Egyptian sufferers on upkeep hemodialysis? Eur.J.Gen.Med 2009;6(2):7-15.

Safarinejad, M. R., Hosseini, S. Y., and Kolahi, A. A. Comparability of vitamin E and propionyl-L-carnitine, individually or together, in sufferers with early power Peyronie’s illness: a double-blind, placebo managed, randomized research. J Urol. 2007;178(4 Pt 1):1398-1403. View summary.

Sahajwalla, C. G., Helton, E. D., Purich, E. D., Hoppel, C. L., and Cabana, B. E. A number of-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg pill versus 1-g chewable pill versus enteral answer in wholesome grownup male volunteers. J Pharm Sci 1995;84(5):627-633. View summary.

Sakurabayashi, T., Miyazaki, S., Yuasa, Y., Sakai, S., Suzuki, M., Takahashi, S., and Hirasawa, Y. L-carnitine supplementation decreases the left ventricular mass in sufferers present process hemodialysis. Circ.J 2008;72(6):926-931. View summary.

Sakurauchi, Y., Matsumoto, Y., Shinzato, T., Takai, I., Nakamura, Y., Sato, M., Nakai, S., Miwa, M., Morita, H., Miwa, T., Amano, I., and Maeda, Okay. Results of L-carnitine supplementation on muscular signs in hemodialyzed sufferers. Am J Kidney Dis. 1998;32(2):258-264. View summary.

Salonia, A. Editorial touch upon: Antioxidant remedy related to sildenafil reduces monocyte activation and markers of endothelial injury in sufferers with diabetic erectile dysfunction: a double-blind, placebo-controlled research. Eur.Urol. 2007;52(6):1775-1776. View summary.

Sandor, A., Pecsuvac, Okay., Kerner, J., and Alkonyi, I. On carnitine content material of the human breast milk. Pediatr.Res 1982;16(2):89-91. View summary.

Santo, S. S., Sergio, N., Luigi, D. P., Giuseppe, M., Margherita, F., Gea, O. C., Roberto, F., Gabriella, C., Giuseppe, P., and Massimiliano, A. Impact of PLC on useful parameters and oxidative profile in sort 2 diabetes-associated PAD. Diabetes Res.Clin Pract. 2006;72(3):231-237. View summary.

Sarafoglou, Okay., Tridgell, A. H., Bentler, Okay., Redlinger-Grosse, Okay., Berry, S. A., and Schimmenti, L. A. Cardiac conduction enchancment in two heterozygotes for major carnitine deficiency on L-carnitine supplementation. Clin Genet. 2010;78(2):191-194. View summary.

Sarris, J., Kean, J., Schweitzer, I., and Lake, J. Complementary medicines (natural and dietary merchandise) within the remedy of Consideration Deficit Hyperactivity Dysfunction (ADHD): a scientific assessment of the proof. Complement Ther Med 2011;19(4):216-227. View summary.

Schiavoni, G., Lucente, M., Di Folca, A., Alessandri, N., Mongiardo, R., and Manzoli, U. [The anti-arrhythmic effect of L-carnitine in subjects with ischemic cardiopathy]. Clin Ter. 2-15-1981;96(3):263-270. View summary.

Schoffski, P., Guillem, V., Garcia, M., Rivera, F., Tabernero, J., Cullell, M., Lopez-Martin, J. A., Pollard, P., Dumez, H., del Muro, X. G., and Paz-Ares, L. Part II randomized research of Plitidepsin (Aplidin), alone or in affiliation with L-carnitine, in sufferers with unresectable superior renal cell carcinoma. Mar.Medicine 2009;7(1):57-70. View summary.

Segura-Bruna, N., Rodriguez-Campello, A., Puente, V., and Roquer, J. Valproate-induced hyperammonemic encephalopathy. Acta Neurol.Scand. 2006;114(1):1-7. View summary.

Semeniuk, J., Shalansky, Okay. F., Taylor, N., Jastrzebski, J., and Cameron, E. C. Analysis of the impact of intravenous l-carnitine on high quality of life in power hemodialysis sufferers. Clin Nephrol. 2000;54(6):470-477. View summary.

Search engine optimization, J. T., Kim, Okay. T., Moon, M. H., and Kim, W. T. The importance of microsurgical varicocelectomy within the remedy of subclinical varicocele. Fertil.Steril. 2010;93(6):1907-1910. View summary.

Seong, S. H., Cho, S. C., Park, Y., and Cha, Y. S. L-carnitine-supplemented parenteral vitamin improves fats metabolism however fails to help compensatory progress in untimely Korean infants. Nutr.Res. 2010;30(4):233-239. View summary.

Serjeant, B. E., Harris, J., Thomas, P., and Serjeant, G. R. Propionyl-L-carnitine in power leg ulcers of homozygous sickle cell illness: a pilot research. J Am Acad.Dermatol. 1997;37(3 Pt 1):491-493. View summary.

Sethumadhavan, S. and Chinnakannu, P. Carnitine and lipoic acid alleviates protein oxidation in coronary heart mitochondria throughout getting older course of. Biogerontology. 2006;7(2):101-109. View summary.

Shakeri, A., Tabibi, H., and Hedayati, M. Results of L-carnitine complement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis sufferers with Lp (a) hyperlipoproteinemia. Hemodial.Int. 2010;14(4):498-504. View summary.

Sharifi, A. M., Zare, B., Keshavarz, M., and Ghaderpanahi, M. Impact of brief time period remedy of L-carnitine on tissue ACE exercise in streptozotocin-induced diabetic rats. Pathophysiology. 2009;16(1):53-56. View summary.

Shi, J. Z., Zhang, S. S., Zhang, Z., Liang, Q., Shi, Y., Hua, J. L., and Solar, T. [Expressions of sperm-specific genes in carnitine-cultured testis sperm of obstructive azoospermia patients]. Zhonghua Nan.Ke.Xue. 2010;16(6):504-509. View summary.

Shojaei, M., Djalali, M., Khatami, M., Siassi, F., and Eshraghian, M. Results of carnitine and coenzyme Q10 on lipid profile and serum ranges of lipoprotein(a) in upkeep hemodialysis sufferers on statin remedy. Iran J Kidney Dis 2011;5(2):114-118. View summary.

Shortland, G. J., Walter, J. H., Stroud, C., Fleming, P. J., Speidel, B. D., and Marlow, N. Randomised managed trial of L-carnitine as a dietary complement in preterm infants. Arch Dis.Little one Fetal Neonatal Ed 1998;78(3):F185-F188. View summary.

Siami, G., Clinton, M. E., Mrak, R., Griffis, J., and Stone, W. Analysis of the impact of intravenous L-carnitine remedy on operate, construction and fatty acid metabolism of skeletal muscle in sufferers receiving power hemodialysis. Nephron 1991;57(3):306-313. View summary.

Sigman, M., Glass, S., Campagnone, J., and Pryor, J. L. Carnitine for the remedy of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial. Fertil.Steril. 2006;85(5):1409-1414. View summary.

Signorelli, S. S., Fatuzzo, P., Rapisarda, F., Neri, S., Ferrante, M., Oliveri, Conti G., Fallico, R., Di, Pino L., Pennisi, G., Celotta, G., and Anzaldi, M. Propionyl-L-carnitine remedy: results on endothelin-1 and homocysteine ranges in sufferers with peripheral arterial illness and end-stage renal illness. Kidney Blood Press Res. 2006;29(2):100-107. View summary.

Signorelli, S. S., Fatuzzo, P., Rapisarda, F., Neri, S., Ferrante, M., Oliveri, Conti G., Fallico, R., Di, Pino L., Pennisi, G., Celotta, G., and Massimiliano, A. A randomised, managed medical trial evaluating adjustments in therapeutic efficacy and oxidative parameters after remedy with propionyl L-carnitine in sufferers with peripheral arterial illness requiring haemodialysis. Medicine Getting old 2006;23(3):263-270. View summary.

Silverio, R., Laviano, A., Rossi, Fanelli F., and Seelaender, M. L-Carnitine induces restoration of liver lipid metabolism in most cancers cachexia. Amino.Acids 2012;42(5):1783-1792. View summary.

Sirtori, C. R., Calabresi, L., Ferrara, S., Pazzucconi, F., Bondioli, A., Baldassarre, D., Birreci, A., and Koverech, A. L-carnitine reduces plasma lipoprotein(a) ranges in sufferers with hyper Lp(a). Nutr Metab Cardiovasc.Dis. 2000;10(5):247-251. View summary.

Sloan, R. S., Kastan, B., Rice, S. I., Sallee, C. W., Yuenger, N. J., Smith, B., Ward, R. A., Brier, M. E., and Golper, T. A. High quality of life throughout and between hemodialysis therapies: function of L- carnitine supplementation. Am J Kidney Dis 1998;32(2):265-272. View summary.

Smith, W. A., Fry, A. C., Tschume, L. C., and Bloomer, R. J. Impact of glycine propionyl-L-carnitine on cardio and anaerobic train efficiency. Int.J Sport Nutr.Exerc.Metab 2008;18(1):19-36. View summary.

Socha, P., Horvath, A., Vajro, P., Dziechciarz, P., Dhawan, A., and Szajewska, H. Pharmacological interventions for nonalcoholic fatty liver illness in adults and in youngsters: a scientific assessment. J Pediatr.Gastroenterol.Nutr. 2009;48(5):587-596. View summary.

Soczynska, J. Okay., Kennedy, S. H., Chow, C. S., Woldeyohannes, H. O., Konarski, J. Z., and McIntyre, R. S. Acetyl-L-carnitine and alpha-lipoic acid: doable neurotherapeutic brokers for temper issues? Professional.Opin.Investig.Medicine 2008;17(6):827-843. View summary.

Sohn HJ, Choi GB Yoon KI. L-Carnitine in upkeep hemo- dialysis medical, lipid and biochemical results. Kor J Nephrol 1992;11:260-269.

Sood, A., Barton, D. L., Bauer, B. A., and Loprinzi, C. L. A important assessment of complementary therapies for cancer-related fatigue. Integr.Most cancers Ther 2007;6(1):8-13. View summary.

Sotobatake I, Noda S, Hayashi H, and et al. Medical analysis of the results of levocarnitine chloride (LC-80) on excercise tolerance in steady angina pectoris by the serial multistage treadmill train testing: a multicenter, double-blind research. Jpn J Clin Pharmacol Ther 1989;20(3):607-618.

Soyucen, E., Demirci, E., and Aydin, A. Outpatient remedy of propionic acidemia-associated hyperammonemia with N-carbamoyl-L-glutamate in an toddler. Clin Ther 2010;32(4):710-713. View summary.

Spasov, A. A., Iezhitsa, I. N., Kravchenko, M. S., Pisarev, V. B., and Snigur, G. L. Results of L-, D-, and DL-carnitine on morphometric parameters of skeletal muscle and train efficiency of laboratory animals receiving carnitine-deficient food plan. Bull.Exp.Biol.Med. 2006;142(4):458-460. View summary.

Spiekerkoetter, U., Bastin, J., Gillingham, M., Morris, A., Wijburg, F., and Wilcken, B. Present points concerning remedy of mitochondrial fatty acid oxidation issues. J Inherit.Metab Dis 2010;33(5):555-561. View summary.

Spiekerkoetter, U., Lindner, M., Santer, R., Grotzke, M., Baumgartner, M. R., Boehles, H., Das, A., Haase, C., Hennermann, J. B., Karall, D., de, Klerk H., Knerr, I., Koch, H. G., Plecko, B., Roschinger, W., Schwab, Okay. O., Scheible, D., Wijburg, F. A., Zschocke, J., Mayatepek, E., and Wendel, U. Administration and consequence in 75 people with long-chain fatty acid oxidation defects: outcomes from a workshop. J Inherit.Metab Dis 2009;32(4):488-497. View summary.

Spiering, B. A., Kraemer, W. J., Hatfield, D. L., Vingren, J. L., Fragala, M. S., Ho, J. Y., Thomas, G. A., Hakkinen, Okay., and Volek, J. S. Results of L-carnitine L-tartrate supplementation on muscle oxygenation responses to resistance train. J Power.Cond.Res. 2008;22(4):1130-1135. View summary.

Spiering, B. A., Kraemer, W. J., Vingren, J. L., Hatfield, D. L., Fragala, M. S., Ho, J. Y., Maresh, C. M., Anderson, J. M., and Volek, J. S. Responses of criterion variables to completely different supplemental doses of L-carnitine L-tartrate. J Power.Cond.Res. 2007;21(1):259-264. View summary.

Sproule, D. M., Dyme, J., Coku, J., de, Vinck D., Rosenzweig, E., Chung, W. Okay., and De Vivo, D. C. Pulmonary artery hypertension in a baby with MELAS due to some extent mutation of the mitochondrial tRNA((Leu)) gene (m.3243A > G). J Inherit.Metab Dis 1-7-2008; View summary.

Srivastava DK, Kumar S Misra AP. Reversal of haemodialysis induced hypertriacylglycerolemia by L-carnitine. Indian J Clin Biochem 1992;7:19-21.

Stuessi, C., Hofer, P., Meier, C., and Boutellier, U. L -Carnitine and the restoration from exhaustive endurance train: a randomised, double-blind, placebo-controlled trial. Eur J Appl Physiol 2005;95(5-6):431-435. View summary.

Suchitra, M. M., Ashalatha, V. L., Sailaja, E., Rao, A. M., Reddy, V. S., Bitla, A. R., Sivakumar, V., and Rao, P. V. The impact of L-carnitine supplementation on lipid parameters, inflammatory and dietary markers in upkeep hemodialysis sufferers. Saudi.J Kidney Dis Transpl. 2011;22(6):1155-1159. View summary.

Sugino, T., Aoyagi, S., Shirai, T., Kajimoto, Y., and Kajimoto, O. Results of Citric Acid and l-Carnitine on Bodily Fatigue. J Clin Biochem.Nutr. 2007;41(3):224-230. View summary.

Sulkers, E. J., Lafeber, H. N., Degenhart, H. J., Przyrembel, H., Schlotzer, E., and Sauer, P. J. Results of excessive carnitine supplementation on substrate utilization in low-birth-weight infants receiving whole parenteral vitamin. Am J Clin Nutr 1990;52(5):889-894. View summary.

Sum CF, Winocour PH, Agius L, and et al. Does oral L-carnitine alter plasma triglyceride ranges in hypertriglyceridaemic topics with or with out non-insulin dependent diabetes mellitus? Diabetes Nutr Metab Clin Exp 1992;5(3):175-181.

Solar, Z. J., Yang, C. B., Wang, H., and Li, Y. [The impact of L-carnitine administration on the serum level of myocardium injury markers in patients with acute carbon monoxide poisoning]. Zhongguo Wei Zhong.Bing.Ji.Jiu.Yi Xue 2011;23(12):739-742. View summary.

Sunamori M, Nakagawa T, Fujisawa S, and et al. Myocardial response to pretreatment with L-carnitine in sufferers with cardiac valve alternative. Vascular Surgical procedure 1991;25(8):607-617.

Suzuki, Y., Narita, M., and Yamazaki, N. Results of L-carnitine on arrhythmias throughout hemodialysis. Jpn Coronary heart J 1982;23(3):349-359. View summary.

Swart I, Rossouw J, Loots JM, and et al. The impact of L-carnitine supplementation on plasma carnitine ranges and numerous efficiency parameters of male marathon athletes. Nutr Res 1997;17:405-414.

Swoboda, Okay. J., Scott, C. B., Crawford, T. O., Simard, L. R., Reyna, S. P., Krosschell, Okay. J., Acsadi, G., Elsheik, B., Schroth, M. Okay., D’Anjou, G., LaSalle, B., Prior, T. W., Sorenson, S. L., Maczulski, J. A., Bromberg, M. B., Chan, G. M., and Kissel, J. T. SMA CARNI-VAL trial half I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy. PLoS.One. 2010;5(8):e12140. View summary.

Tabibi, H., Hakeshzadeh, F., Hedayati, M., and Malakoutian, T. Results of l-carnitine complement on serum amyloid A and vascular irritation markers in hemodialysis sufferers: a randomized managed trial. J Ren Nutr. 2011;21(6):485-491. View summary.

Tanner, L. M., Nanto-Salonen, Okay., Rashed, M. S., Kotilainen, S., Aalto, M., Venetoklis, J., Niinikoski, H., Huoponen, Okay., and Simell, O. Carnitine deficiency and L-carnitine supplementation in lysinuric protein intolerance. Metabolism 2008;57(4):549-554. View summary.

Tarantini, G., Scrutinio, D., Bruzzi, P., Boni, L., Rizzon, P., and Iliceto, S. Metabolic remedy with L-carnitine in acute anterior ST section elevation myocardial infarction. A randomized managed trial. Cardiology 2006;106(4):215-223. View summary.

Tarighat, Esfanjani A., Mahdavi, R., Ebrahimi, Mameghani M., Talebi, M., Nikniaz, Z., and Safaiyan, A. The consequences of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis. Biol.Hint Elem.Res 2012;150(1-3):42-48. View summary.

Tejani, A. M., Wasdell, M., Spiwak, R., Rowell, G., and Nathwani, S. Carnitine for fatigue in a number of sclerosis. Cochrane.Database.Syst.Rev. 2010;(2):CD007280. View summary.

Tejani, A. M., Wasdell, M., Spiwak, R., Rowell, G., and Nathwani, S. Carnitine for fatigue in a number of sclerosis. Cochrane.Database.Syst.Rev. 2012;5:CD007280. View summary.

Thomas, S., Fischer, F. P., Mettang, T., Pauli-Magnus, C., Weber, J., and Kuhlmann, U. Results of L-carnitine on leukocyte operate and viability in hemodialysis sufferers: A double-blind randomized trial. Am.J Kidney Dis 1999;34(4):678-687. View summary.

Thomsen, J. H., Shug, A. L., Yap, V. U., Patel, A. Okay., Karras, T. J., and DeFelice, S. L. Improved pacing tolerance of the ischemic human myocardium after administration of carnitine. Am J Cardiol. 1979;43(2):300-306. View summary.

Tomassini, V., Pozzilli, C., Onesti, E., Pasqualetti, P., Marinelli, F., Pisani, A., and Fieschi, C. Comparability of the results of acetyl L-carnitine and amantadine for the remedy of fatigue in a number of sclerosis: outcomes of a pilot, randomised, double-blind, crossover trial. J Neurol.Sci 3-15-2004;218(1-2):103-108. View summary.

Toptas, B., Baykal, A., Yesilipek, A., Isbir, M., Kupesiz, A., Yalcin, O., and Baskurt, O. Okay. L-carnitine deficiency and purple blood cell mechanical impairment in beta-thalassemia main. Clin Hemorheol.Microcirc. 2006;35(3):349-357. View summary.

Torrioli, M. G., Vernacotola, S., Mariotti, P., Bianchi, E., Calvani, M., De Gaetano, A., Chiurazzi, P., and Neri, G. Double-blind, placebo-controlled research of L-acetylcarnitine for the remedy of hyperactive habits in fragile X syndrome. Am.J Med Genet. 12-3-1999;87(4):366-368. View summary.

Torrioli, M. G., Vernacotola, S., Peruzzi, L., Tabolacci, E., Mila, M., Militerni, R., Musumeci, S., Ramos, F. J., Frontera, M., Sorge, G., Marzullo, E., Romeo, G., Vallee, L., Veneselli, E., Cocchi, E., Garbarino, E., Moscato, U., Chiurazzi, P., D’Iddio, S., Calvani, M., and Neri, G. A double-blind, parallel, multicenter comparability of L-acetylcarnitine with placebo on the eye deficit hyperactivity dysfunction in fragile X syndrome boys. Am.J Med.Genet.A 4-1-2008;146(7):803-812. View summary.

Touati, G., Valayannopoulos, V., Point out, Okay., de, Lonlay P., Jouvet, P., Depondt, E., Assoun, M., Souberbielle, J. C., Rabier, D., Ogier de, Baulny H., and Saudubray, J. M. Methylmalonic and propionic acidurias: administration with or without a number of dietary supplements of particular amino acid combination. J Inherit.Metab Dis 2006;29(2-3):288-298. View summary.

Trappe, S. W., Costill, D. L., Goodpaster, B., Vukovich, M. D., and Fink, W. J. The consequences of L-carnitine supplementation on efficiency throughout interval swimming. Int J Sports activities Med 1994;15(4):181-185. View summary.

Trivelli G, Vitali P Girmenia S Castelli F. Trattamento della dislipidemia dell’emodializzato con L-carnitina. Clin Eur 1983;22:405-415.

Trovato GM, Ginardi V, Di Marco V, and et al. Lengthy-term l-carnitine remedy of power anaemia of sufferers with end-stage renal failure. Curr Ther Res 1982;31:1042-1048.

Turpeinen AK, Kuikka JT, Vanninen E, and et al. Lengthy-term results of acetyl-l-carnitine on myocardial sympathetic innervation in diabetic sufferers. Diabetologia 1997;40(1):A32.

Turpeinen, A. Okay., Kuikka, J. T., Vanninen, E., Yang, J., and Uusitupa, M. I. Lengthy-term impact of acetyl-L-carnitine on myocardial 123I-MIBG uptake in sufferers with diabetes. Clin Auton.Res 2000;10(1):13-16. View summary.

Uppin, M. S., Sundaram, C., Meena, A. Okay., Reddy, Okay. M., Reddy, Okay. Okay., Vanniarajan, A., and Thangaraj, Okay. Lipid storage myopathies with uncommon medical manifestations. Neurol.India 2008;56(3):391-393. View summary.

Uzun, N., Sarikaya, S., Uluduz, D., and Aydin, A. Peripheric and automated neuropathy in youngsters with sort 1 diabetes mellitus: the impact of L-carnitine remedy on the peripheral and autonomic nervous system. Electromyogr.Clin Neurophysiol. 2005;45(6):343-351. View summary.

Vacha, G. M., Giorcelli, G., D’Iddio, S., Valentini, G., Bagiella, E., Procopio, A., di Donato, S., Ashbrook, D., and Corsi, M. L-carnitine addition to dialysis fluid. A therapeutic various for hemodialysis sufferers. Nephron 1989;51(2):237-242. View summary.

Valcour, V., Yeh, T. M., Bartt, R., Clifford, D., Gerschenson, M., Evans, S. R., Cohen, B. A., Ebenezer, G. J., Hauer, P., Millar, L., Gould, M., Tran, P., Shikuma, C., Souza, S., and McArthur, J. C. Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV an infection. HIV.Med. 2009;10(2):103-110. View summary.

van Dalen, E. C., Caron, H. N., Dickinson, H. O., and Kremer, L. C. Cardioprotective interventions for most cancers sufferers receiving anthracyclines. Cochrane.Database.Syst.Rev. 2008;(2):CD003917. View summary.

van Dalen, E. C., Caron, H. N., Dickinson, H. O., and Kremer, L. C. Cardioprotective interventions for most cancers sufferers receiving anthracyclines. Cochrane.Database.Syst.Rev. 2011;(6):CD003917. View summary.

Van Oudheusden, L. J. and Scholte, H. R. Efficacy of carnitine within the remedy of kids with attention-deficit hyperactivity dysfunction. Prostaglandins Leukot.Essent.Fatty Acids 2002;67(1):33-38. View summary.

Vaux, E. C., Taylor, D. J., Altmann, P., Rajagopalan, B., Graham, Okay., Cooper, R., Bonomo, Y., and Types, P. Results of carnitine supplementation on muscle metabolism by means of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal illness. Nephron Clin.Pract. 2004;97(2):c41-c48. View summary.

Verrina, E., Caruso, U., Calevo, M. G., Emma, F., Sorino, P., De, Palo T., Lavoratti, G., Turrini, Dertenois L., Cassanello, M., Cerone, R., and Perfumo, F. Impact of carnitine supplementation on lipid profile and anemia in youngsters on power dialysis. Pediatr.Nephrol. 2007;22(5):727-733. View summary.

Villani, R. G., Gannon, J., Self, M., and Wealthy, P. A. L-Carnitine supplementation mixed with cardio coaching doesn’t promote weight reduction in reasonably overweight girls. Int J Sport Nutr Exerc.Metab 2000;10(2):199-207. View summary.

Vitali, G., Parente, R., and Melotti, C. Carnitine supplementation in human idiopathic asthenospermia: medical outcomes. Medicine Exp Clin Res 1995;21(4):157-159. View summary.

Vivekanandan, S. and Nayak, S. D. Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: a case report and an replace. Ann.Indian Acad.Neurol. 2010;13(2):145-147. View summary.

Volek, J. S., Judelson, D. A., Silvestre, R., Yamamoto, L. M., Spiering, B. A., Hatfield, D. L., Vingren, J. L., Quann, E. E., Anderson, J. M., Maresh, C. M., and Kraemer, W. J. Results of carnitine supplementation on flow-mediated dilation and vascular inflammatory responses to a high-fat meal in wholesome younger adults. Am.J Cardiol. 11-15-2008;102(10):1413-1417. View summary.

Wadman, R. I., Bosboom, W. M., van den Berg, L. H., Wokke, J. H., Iannaccone, S. T., and Vrancken, A. F. Drug remedy for spinal muscular atrophy sorts II and III. Cochrane.Database.Syst.Rev. 2011;(12):CD006282. View summary.

Wadman, R. I., Bosboom, W. M., van der Pol, W. L., van den Berg, L. H., Wokke, J. H., Iannaccone, S. T., and Vrancken, A. F. Drug remedy for spinal muscular atrophy sorts II and III. Cochrane.Database.Syst.Rev. 2012;4:CD006282. View summary.

Wadzinski, J., Franks, R., Roane, D., and Bayard, M. Valproate-associated hyperammonemic encephalopathy. J Am.Board Fam.Med. 2007;20(5):499-502. View summary.

Waldner, R., Laschan, C., Lohninger, A., Gessner, M., Tuchler, H., Huemer, M., Spiegel, W., and Karlic, H. Results of doxorubicin-containing chemotherapy and a mix with L-carnitine on oxidative metabolism in sufferers with non-Hodgkin lymphoma. J Most cancers Res.Clin Oncol. 2006;132(2):121-128. View summary.

Wall, B. T., Stephens, F. B., Constantin-Teodosiu, D., Marimuthu, Okay., Macdonald, I. A., and Greenhaff, P. L. Rising muscle carnitine content material alters muscle gasoline metabolism and improves train efficiency in people. Japanese J.Bodily Health Sports activities Med. 2011;60(1):85.

Wang, J. and Wang, X. The consequences of L-carnitine on human stamina. China Meals Components 2003;5:40-43.

Wang, S. B., Weng, W. C., Lee, N. C., Hwu, W. L., Fan, P. C., and Lee, W. T. Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-White syndrome and cardiomyopathy. Pediatr.Neonatol. 2008;49(4):145-149. View summary.

Wang, Y. X., Yang, S. W., Qu, C. B., Huo, H. X., Li, W., Li, J. D., Chang, X. L., and Cai, G. Z. [L-carnitine: safe and effective for asthenozoospermia]. Zhonghua Nan.Ke.Xue. 2010;16(5):420-422. View summary.

Warady, B. A., Borum, P., Stall, C., Millspaugh, J., Taggart, E., and Lum, G. Carnitine standing of pediatric sufferers on steady ambulatory peritoneal dialysis. Am J Nephrol 1990;10(2):109-114. View summary.

Watanabe, S., Ajisaka, R., Masuoka, T., Yamanouchi, T., Saitou, T., Toyama, M., Takeyasu, N., Sakamoto, Okay., and Sugishita, Y. Results of L- and DL-carnitine on sufferers with impaired train tolerance. Jpn Coronary heart J 1995;36(3):319-331. View summary.

Weigel, C., Kiener, C., Meier, N., Schmid, P., Rauh, M., Rascher, W., and Knerr, I. Carnitine standing in early-treated youngsters, adolescents and younger adults with phenylketonuria on low phenylalanine diets. Ann.Nutr.Metab 2008;53(2):91-95. View summary.

Weinhandl, E. D., Rao, M., Gilbertson, D. T., Collins, A. J., and Pereira, B. J. Protecting impact of intravenous levocarnitine on subsequent-month hospitalization amongst prevalent hemodialysis sufferers, 1998 to 2003. Am.J Kidney Dis 2007;50(5):803-812. View summary.

Weschler, A., Aviram, M., Levin, M., Higher, O. S., and Brook, J. G. Excessive dose of L-carnitine will increase platelet aggregation and plasma triglyceride ranges in uremic sufferers on hemodialysis. Nephron 1984;38(2):120-124. View summary.

Williams, S. F., Alvarez, J. R., Pedro, H. F., and Apuzzio, J. J. Glutaric aciduria sort II and narcolepsy in being pregnant. Obstet.Gynecol. 2008;111(2 Pt 2):522-524. View summary.

Wolfe, L. A., He, M., Vockley, J., Payne, N., Rhead, W., Hoppel, C., Spector, E., Gernert, Okay., and Gibson, Okay. M. Novel ETF dehydrogenase mutations in a affected person with delicate glutaric aciduria sort II and complicated II-III deficiency in liver and muscle. J Inherit.Metab Dis 11-19-2010; View summary.

Wu, Z. M., Lu, X., Wang, Y. W., Solar, J., Tao, J. W., Yin, F. H., and Cheng, H. J. [Short-term medication of L-carnitine before intracytoplasmic sperm injection for infertile men with oligoasthenozoospermia]. Zhonghua Nan.Ke.Xue 2012;18(3):253-256. View summary.

Wyss, V., Ganzit, G. P., and Rienzi, A. Results of L-carnitine administration on VO2max and the aerobic- anaerobic threshold in normoxia and acute hypoxia. Eur J Appl Physiol Occup.Physiol 1990;60(1):1-6. View summary.

Xie, H., Tang, S. Y., Li, H., Luo, X. H., Yuan, L. Q., Wang, D., and Liao, E. Y. L-carnitine protects towards apoptosis of murine MC3T3-E1 osteoblastic cells. Amino.Acids 2008;35(2):419-423. View summary.

Xie, J., Zeng, Q., and Wang, L. The protecting impact of L-carnitine on ischemia-reperfusion coronary heart. J Huazhong.Univ Sci Technolog.Med.Sci 2006;26(2):188-191. View summary.

Xue, Y. Z., Wang, L. X., Liu, H. Z., Qi, X. W., Wang, X. H., and Ren, H. Z. L-carnitine as an adjunct remedy to percutaneous coronary intervention for non-ST elevation myocardial infarction. Cardiovasc.Medicine Ther 2007;21(6):445-448. View summary.

Yang, L., Yin, H., Yang, R., and Huang, X. Prognosis, remedy and consequence of glutaric aciduria sort I in Zhejiang Province, China. Med.Sci Monit. 2011;17(7):H55-H59. View summary.

Yderstraede, Okay. B., Pedersen, F. B., Dragsholt, C., Trostmann, A., Laier, E., and Larsen, H. F. The impact of L-carnitine on lipid metabolism in sufferers on power haemodialysis. Nephrol.Dial.Transplant. 1987;1(4):238-241. View summary.

Ye, J., Li, C. J., and Liu, J. H. [A clinical analysis of methylmalonic acidemia in adolescents]. Zhonghua Nei Ke.Za Zhi. 2008;47(10):823-825. View summary.

Yeh, Y. Y., Cooke, R. J., and Zee, P. Impairment of lipid emulsion metabolism related to carnitine insufficiency in untimely infants. J Pediatr Gastroenterol Nutr 1985;4(5):795-798. View summary.

Yokoi, Okay., Ito, T., Maeda, Y., Nakajima, Y., Ueta, A., Nomura, T., Koyama, N., Kato, I., Suzuki, S., Kurono, Y., Sugiyama, N., and Togari, H. Acylcarnitine profiles throughout carnitine loading and fasting checks in a Japanese affected person with medium-chain acyl-CoA dehydrogenase deficiency. Tohoku J Exp.Med. 2007;213(4):351-359. View summary.

Youle, M. Acetyl-L-carnitine in HIV-associated antiretroviral poisonous neuropathy. CNS.Medicine 2007;21 Suppl 1:25-30. View summary.

Youle, M. and Osio, M. A double-blind, parallel-group, placebo-controlled, multicentre research of acetyl L-carnitine within the symptomatic remedy of antiretroviral poisonous neuropathy in sufferers with HIV-1 an infection. HIV.Med. 2007;8(4):241-250. View summary.

Younger, P., Finn, B. C., Alvarez, F., Bruetman, J. E., and Trimarchi, H. [Valproate-associated hyperammonemic encephalopathy. Report of one case]. Rev.Med.Chil. 2007;135(11):1446-1449. View summary.

Zanardi, R. and Smeraldi, E. A double-blind, randomised, managed medical trial of acetyl-L-carnitine vs. amisulpride within the remedy of dysthymia. Eur.Neuropsychopharmacol. 2006;16(4):281-287. View summary.

Zhang, J. M., Gu, X. F., Shao, X. H., Tune, X. Q., Han, L. S., Ye, J., Qiu, W. J., Gao, X. L., Wang, Y., and Wang, M. X. [Values of tandem mass spectrometry in etiologic diagnosis of cerebral developmental retardation]. Zhonghua Er.Ke.Za Zhi. 2007;45(12):932-936. View summary.

Zhang, W., Miao, J., Zhang, G., Liu, R., Zhang, D., Wan, Q., Yu, Y., Zhao, G., and Li, Z. Muscle carnitine deficiency: grownup onset lipid storage myopathy with sensory neuropathy. Neurol.Sci 2010;31(1):61-64. View summary.

Zhang, X. L. and Ge, H. Medical observations on treating ischemic cardiomyopathy utilizing Fasudil and L-carnitine. Chinese language J.Pract.Inner Med. 2011;31(5):376-377.

Zhang, Y., Tune, J. Q., Liu, P., Yan, R., Dong, J. H., Yang, Y. L., Wang, L. F., Jiang, Y. W., Zhang, Y. H., Qin, J., and Wu, X. R. [Clinical studies on fifty-seven Chinese patients with combined methylmalonic aciduria and homocysteinemia]. Zhonghua Er.Ke.Za Zhi. 2007;45(7):513-517. View summary.

Zhao, J. L., Gao, D. Z., Liu, D., He, H. H., She, Q., and Yin, Y. H. Enchancment of train tolerance by L-carnitine in sufferers with cardiac syndrome X. Chin.Hosp.Pharm.J. 2010;30(17):1460-1463.

Zhou, X., Liu, F., and Zhai, S. Impact of L-carnitine and/or L-acetyl-carnitine in vitamin remedy for male infertility: a scientific assessment. Asia Pac.J Clin Nutr. 2007;16 Suppl 1:383-390. View summary.

Zilleruelo, G., Novak, M., Hsia, S. L., Goldberg, R., Abitbol, C., Monkus, E., and Strauss, J. Impact of dialysate composition on the lipid response to L-carnitine supplementation. Kidney Int Suppl 1989;27:S259-S263. View summary.

Zwickler, T., Lindner, M., Aydin, H. I., Baumgartner, M. R., Bodamer, O. A., Burlina, A. B., Das, A. M., DeKlerk, J. B., Gokcay, G., Grunewald, S., Guffon, N., Maier, E. M., Morava, E., Geb, S., Schwahn, B., Walter, J. H., Wendel, U., Wijburg, F. A., Muller, E., Kolker, S., and Horster, F. Diagnostic work-up and administration of sufferers with remoted methylmalonic acidurias in European metabolic centres. J Inherit.Metab Dis 2008;31(3):361-367. View summary.

12761 Benvenga S, Amato A, Calvani M, Trimarchi F. Results of carnitine on thyroid hormone motion. Ann N Y Acad Sci 2004;1033:158-67. View summary.

Abbasnezhad A, Choghakhori R, Kashkooli S, Alipour M, Asbaghi O, Mohammadi R. Impact of L-carnitine on liver enzymes and biochemical components in hepatic encephalopathy: A scientific assessment and meta-analysis. J Gastroenterol Hepatol 2019;34(12):2062-70. doi: 10.1111/jgh.14765. View summary.

Abbasnezhad A, Hasanavand A, Falahi E, Kashkooli S, Asbaghi O, Choghakhori R. Impact of L-carnitine supplementation on lipid profiles of sufferers with liver illness: a scientific assessment and meta-analysis. Prev Nutr Meals Sci 2020;25(2):124-32. View summary.

Abdollahi H, Abdolahi M, Sedighiyan M, Jafarieh A. The impact of L-carnitine on mortality charge in septic sufferers: a scientific assessment and meta-analysis on randomized medical trials. Endocr Metab Immune Disord Drug Targets 2020. On-line forward of print. View summary.

Agarwal A, Sengupta P, Durairajanayagam D. Function of L-carnitine in feminine infertility. Reprod Biol Endocrinol 2018;16(1):5. View summary.

Ahmad S, Robertson HT, Golper TA, et al. Multicenter trial of L-carnitine in upkeep hemodialysis sufferers. II. Medical and biochemical results. Kidney Int 1990;38:912-8. View summary.

Altunbasak S, Baytok V, Tasouji M, et al. Asymptomatic hyperammonemia in youngsters handled with valproic acid. J Little one Neurol 1997;12:461-3.

An JH, Kim YJ, Kim KJ, et al. L-carnitine supplementation for the administration of fatigue in sufferers with hypothyroidism on levothyroxine remedy: a randomized, double-blind, placebo-controlled trial. Endocr J. 2016;63(10):885-95. View summary.

Anand I, Chandrashekhan Y, De Giuli F, et al. Acute and power results of propionyl-L-carnitine on the hemodynamics, train capability, and hormones in sufferers with congestive coronary heart failure. Cardiovasc Medicine Ther 1998;12:291-9. View summary.

Angelova-Fischer I, Rippke F, Fischer TW, Neufang G, Zillikens D. A double-blind, randomized, vehicle-controlled efficacy evaluation research of a skincare formulation for enchancment of delicate to reasonably extreme zits. J Eur Acad Dermatol Venereol. 2013 Jul;27 Suppl 2:6-11. View summary.

Anon. Carnitor (levocarnitine) bundle insert. Sigma-Tau Prescription drugs Inc, Gaithersburg, MD. December 1999.

Asbaghi O, Kashkooli S, Amini MR, et al. The consequences of L-carnitine supplementation on lipid concentrations inpatients with sort 2 diabetes: A scientific assessment and meta-analysis of randomized medical trials. J Cardiovasc Thorac Res 2020;12(4):246-255. View summary.

Askarpour M, Hadi A, Miraghajani M, Symonds ME, Sheikhi A, Ghaedi E. Helpful results of l-carnitine supplementation for weight administration in obese and overweight adults: An up to date systematic assessment and dose-response meta-analysis of randomized managed trials. Pharmacol Res. 2020;151:104554. View summary.

Askarpour M, Hadi A, Symonds ME, et al. Efficacy of l-carnitine supplementation for administration of blood lipids: A scientific assessment and dose-response meta-analysis of randomized managed trials. Nutr Metab Cardiovasc Dis 2019;29(11):1151-67. doi: 10.1016/j.numecd.2019.07.012. View summary.

Bachmann HU, Hoffmann A. Interplay of meals complement L-carnitine with oral anticoagulant acenocoumarol. Swiss Med Wkly 2004;134:385.

Baek SM, Zheng R, Search engine optimization EJ, Hwang DY, Kim BH. Pharmacokinetic comparisons of two acetyl-L-carnitine formulations in wholesome Korean volunteers. Int J Clin Pharmacol Ther. 2015;53(11):980-6. View summary.

Baghban F, Hosseinzadeh M, Mozaffari-Khosravi H, Dehghan A, Fallahzadeh H. The impact of L-Carnitine supplementation on medical signs, C-reactive protein and malondialdehyde in overweight girls with knee osteoarthritis: a double blind randomized managed trial. BMC Musculoskelet Disord 2021;22(1):195. View summary.

Barditch-Crovo P, Toole J, Hendrix CW, et al. Anti-human immunodeficiency virus (HIV) activitiy, security, and pharmacokinetics of adefovir dipivoxyl (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected sufferers. J Infect Dis 1997;176:406-13. View summary.

Bartels GL, Remme WJ, den Hartog FR, et al. Extra anti-ischemic results of long-term L-propionylcarnitine in anginal sufferers handled with typical antianginal remedy. Cardiovasc Medicine Ther 1995;9:749-53. View summary.

Bartels GL, Remme WJ, Holwerda KJ, Kruijssen DA. Anti-ischaemic efficacy of L-propionylcarnitine – a promising novel metabolic strategy to ischaemia? Eur Coronary heart J 1996;17:414-20. View summary.

Bartels GL, Remme WJ, Pillay M, et al. Results of L-propionylcarnitine on ischemia-induced myocardial dysfunction in males with angina pectoris. Am J Cardiol 1994;74:125-30. View summary.

Baudouin C, Labbé A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the nice, the unhealthy and the ugly. Prog Retin Eye Res. 2010;29(4):312-34. View summary.

Bella R, Biondi R, Raffaele R, Pennisi G. Impact of acetyl-L-carnitine on geriatric sufferers affected by dysthymic issues. Int J Clin Pharmacol Res 1990;10:355-60. View summary.

Benvenga S, Ruggeri RM, Russo A, et al. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone motion, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled medical trial. J Clin Endocrinol Metab 2001;86:3579-94. View summary.

Berthillier G, Eichenberger D, Service HN, et al. Carnitine metabolism in early phases of Duchenne muscular dystrophy. Clin Chim Acta 1982;122:369-75. View summary.

Biagiotti G, Cavallini G. Acetyl-L-carnitine vs tamoxifen within the oral remedy of Peyronie’s illness: a preliminary report. BJU Int 2001;88:63-7.. View summary.

Boehm G, Stahl B. Oligosaccharides from milk. J Nutr 2007;137(3 Suppl 2):847S-849S. View summary.

Bohles H, Sewell AC, Wenzel D. The impact of carnitine supplementation in valproate-induced hyperammonaemia. Acta Paediatr 1996;85:446-9. View summary.

Bonner CM, DeBrie KL, Hug G, et al. Results of parenteral L-carnitine supplementation on fats metabolism and vitamin in untimely neonates. J Pediatr 1995;126:287-92. View summary.

Brass E. Pharmacokinetic issues for the therapeutic use of carnitine in hemodialysis sufferers. Clin Ther 1995;17:176-85. View summary.

Brass EP. Pivalate-generating prodrugs and carnitine homeostasis in man. Pharmacol Rev 2002;54:589-98. View summary.

Brevetti G, Chiariello M, Ferulano G, et al. Will increase in strolling distance in sufferers with peripheral vascular illness handled with L-carnitine: a double-blind, cross-over research. Circulation 1988;77:767-73. View summary.

Brevetti G, Diehm C, Lambert D, et al. European multicenter research on propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol 1999;34:1618-24. View summary.

Brevetti G, Perna S, Sabba C, et al. Impact of propionyl-L-carnitine on high quality of life in intermittent claudication. Am J Cardiol 1997;79:777-80. View summary.

Brevetti G, Perna S, Sabba C, et al. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter research. J Am Coll Cardiol 1995;26:1411-6. View summary.

Brevetti G, Perna S, Sabba C, et al. Superiority of L-propionylcarnitine vs L-carnitine in bettering strolling capability in sufferers with peripheral vascular illness: an acute, intravenous, double-blind, cross-over research. Eur Coronary heart J 1992;13:251-5. View summary.

Brooks JO third, Yesavage JA, Carta A, Bravi D. Acetyl L-carnitine slows decline in youthful sufferers with Alzheimer’s illness: a reanalysis of a double-blind, placebo-controlled research utilizing the trilinear strategy. Int Psychoger 1998;10:193-203. View summary.

Bruno A, Pandolfo G, Crucitti M, Lorusso S, Zoccali RA, Muscatello MR. Acetyl-L-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia: A 12-Week, Open-Label Uncontrolled Preliminary Examine. Clin Neuropharmacol. 2016;39(6):277-80.View summary.

Cacciatore L, Cerio R, Ciarimboli M, et al. The therapeutic impact of L-carnitine in sufferers with exercise-induced steady angina: a managed research. Medicine Exp Clin Res 1991;17:225-35. View summary.

Campos Y, Arenas J. Muscle carnitine deficiency related to zidovudine-induced mitochondrial myopathy. Ann Neurol 1994;36:680-1. View summary.

Capaldo B, Napoli R, Di Bonito P, et al. Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic sufferers. Diabetes Res Clin Pract 1991;14:191-5. View summary.

Caponnetto S, Canale C, Masperone MA, et al. Efficacy of L-propionylcarnitine remedy in sufferers with left ventricular dysfunction. Eur Coronary heart J 1994;15:1267-73. View summary.

Castro-Gago M, Eiris-Punal J, Novo-Rodriguez MI, et al. Serum carnitine ranges in epileptic youngsters earlier than and through remedy with valproic acid, carbamazepine, and phenobarbital. J Little one Neurol 1998;13:546-9. View summary.

Cattaneo CI, Ressico F, Valsesia R, D’Innella P, Ballabio M, Fornaro M. Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically wholesome bipolar affected person: Important assessment of the literature and case report. Drugs (Baltimore). 2017;96(39):e8117 View summary.

Cavallini G, Biagiotti G, Koverech A, Vitali G. Oral propionyl-l-carnitine and intraplaque verapamil within the remedy of superior and resistant Peyronie’s illness. BJU Int 2002;89:895-900. View summary.

Cavallini G, Caracciolo S, Vitali G, et al. Carnitine versus androgen administration within the remedy of sexual dysfunction, depressed temper, and fatigue related to male getting older. Urology 2004;63:641-6. View summary.

Chen N, Yang M, Zhou M, Xiao J, Guo J, He L. L-carnitine for cognitive enhancement in folks with out cognitive impairment. Cochrane Database Syst Rev. 2017;3:CD009374. View summary.

Chen Y, Abbate M, Tang L, Cai G, Gong Z, Wei R, Zhou J, Chen X. L-Carnitine supplementation for adults with end-stage kidney illness requiring upkeep hemodialysis: a scientific assessment and meta-analysis. Am J Clin Nutr. 2014 Feb;99(2):408-22. View summary.

Cherchi A, Lai C, Angelino F, et al. Results of L-carnitine on train tolerance in power steady angina: a multicenter, double-blind, randomized, placebo-controlled, crossover research. Int J Clin Pharmacol Ther Toxicol 1985;23:569-72. View summary.

Cherchi A, Lai C, Onnis E, et al. Propionyl carnitine in steady effort angina. Cardiovasc Medicine Ther 1990;4:481-6. View summary.

Ciacci C, Peluso G, Iannoni E, et al. L-Carnitine within the remedy of fatigue in grownup celiac illness sufferers: a pilot research. Dig Liver Dis 2007;39:922-8. View summary.

Cifone MG, Alesse E, Di Marzio L, et al. Impact of L-carnitine remedy in vivo on apoptosis and ceramide technology in peripheral blood lymphocytes from AIDS sufferers. Proc Assoc Am Physicians 1997;109:146-53. View summary.

Karalis DT, Karalis T, Karalis S, Kleisiari AS. L-Carnitine as a food plan complement in sufferers with sort II diabetes. Cureus. 2020;12(5):e7982. View summary.

Karl M, Rubenstein M, Rudnick C, Brejda J. A multicenter research of nutraceutical drinks for ldl cholesterol (evaluating effectiveness and tolerability). J Clin Lipidology 2012;6:150-158. View summary.

Khajeh B, Dashti-Khavidaki S, Nasiri-Toosi M, Mohammadi Okay, Jafari A. Results of pre-transplant L-carnitine supplementation on major graft dysfunction in liver transplant recipients: a pilot, randomized, placebo-controlled medical trial. Res Pharm Sci. 2019;14(6):504-514. View summary.

Kitano Y, Hashimoto S, Matsumoto H, et al. Oral administration of l-carnitine improves the medical consequence of fertility in sufferers with IVF remedy. Gynecol Endocrinol 2018;34(8):684-8. View summary.

Kletzmayr J, Mayer G, Legenstein E, et al. Anemia and carnitine supplementation in hemodialyzed sufferers. Kidney Int 1999;69:93-106. View summary.

Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL. Intestinal microbiota metabolism of L-carnitine, a nutrient in purple meat, promotes atherosclerosis. Nat Med. 2013 Might;19(5):576-85. View summary.

Krahenbuhl S, Reichen J. Carnitine metabolism in sufferers with power liver illness. Hepatology 1997;25:148-53. View summary.

Krahenbuhl S. Carnitine metabolism in power liver illness. Life Sci 1996;59:1579-99. View summary.

Kubota Okay, Uojima H, Shao X, et al. Extra L-carnitine Lowered the Threat of Hospitalization in Sufferers with Overt Hepatic Encephalopathy on Rifaximin. Dig Dis 2021. View summary.

Kurul S, Dirik E, Iscan A. Serum carnitine ranges throughout oxcarbazepine and carbamazepine monotherapies in youngsters with epilepsy. J Little one Neurol 2003;18:552-4. View summary.

Kuwasawa-Iwasaki M, Io H, Muto M, et al. Results of L-carnitine supplementation in sufferers receiving hemodialysis or peritoneal dialysis. Vitamins 2020;12(11):3371. View summary.

Lai CL, Ahn SH, Lee KS, Um SH, Cho M, Yoon SK, Lee JW, Park NH, Kweon YO, Sohn JH, Lee J, Kim JA, Han KH, Yuen MF. Part IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian sufferers with power hepatitis B. Intestine. 2014 Jun;63(6):996-1004. View summary.

Laker MF, Inexperienced C, Bhuiyan AK, Shuster S. Isotretinoin and serum lipids: research on fatty acid, apolipoprotein and middleman metabolism. Br J Dermatol 1987;117:203-6. View summary.

Latifian S, Hamdi Okay, Totakneh R. Impact of addition of l-carnitine in polycystic ovary syndrome (PCOS) sufferers with clomiphene citrate and gonadotropin resistant. Int J Curr Res Acad Rev 2015;3:469-76.

Lebrun C, Alchaar H, Candito M, et al. Levocarnitine administration in a number of sclerosis sufferers with immunosuppressive therapy-induced fatigue. Mult Scler 2006;12:321-4. View summary.

Lee BJ, Lin JS, Lin YC, Lin PT. Results of L-carnitine supplementation on lipid profiles in sufferers with coronary artery illness. Lipids Well being Dis. 2016;15:107. View summary.

Lenzi A, Sgro P, Salacone P, et al. A placebo-controlled double-blind randomized trial of using mixed l-carnitine and l-acetyl-carnitine remedy in males with asthenozoospermia. Fertil Steril 2004;81:1578-84. View summary.

Liu J, Head E, Kuratsune H, et al. Comparability of the results of L-carnitine and acetyl-L-carnitine on carnitine ranges, ambulatory exercise, and oxidative stress biomarkers within the mind of outdated rats. Ann N Y Acad Sci 2004;1033:117-31. View summary.

Liu Q, Garner P, Wang Y, Huang B, Smith H. Medicine and herbs given to stop hepatotoxicity of tuberculosis remedy: systematic assessment of substances and analysis research. BMC Public Well being. 2008;8:365. View summary.

Löster H, Miehe Okay, Punzel M, et al. Extended oral L-carnitine substitution will increase bicycle ergometer efficiency in sufferers with extreme, ischemically induced cardiac insufficiency. Cardiovasc.Medicine Ther 1999;13:537-46. View summary.

Madsen KL, Preisler N, Orngreen MC, Andersen SP, Olesen JH, Lund AM, Vissing J. Sufferers with medium-chain acyl-coenzyme a dehydrogenase deficiency have impaired oxidation of fats throughout train however no impact of L-carnitine supplementation. J Clin Endocrinol Metab. 2013 Apr;98(4):1667-75. View summary.

Malaguarnera M, Cammalleri L, Gargante MP, et al. L-Carnitine remedy reduces severity of bodily and psychological fatigue and will increase cognitive capabilities in centenarians: a randomized and managed medical trial. Am J Clin Nutr 2007;86:1738-44. View summary.

Mancini M, Rengo F, Lingetti M, et al. Managed research on the therapeutic efficacy of propionyl-L-carnitine in sufferers with congestive coronary heart failure. Arzneimittelforschung 1992;42:1101-4. View summary.

Mantovani G, Maccio A, Madeddu C, et al. Randomized part III medical trial of 5 completely different arms of remedy in 322 sufferers with most cancers cachexia. Oncologist 2010;15:200-11. View summary.

Marconi C, Sassi G, Carpinelli A, Cerretelli P. Results of L-carnitine loading on the cardio and anaerobic efficiency of endurance athletes. Eur J Appl Physiol Occup Physiol 1985;54:131-5. View summary.

Marthaler NP, Visarius T, Kupfer A, Lauterburg BH. Elevated urinary losses of carnitine throughout ifosfamide chemotherapy. Most cancers Chemother Pharmacol 1999;44:170-2. View summary.

Martinez E, Domingo P, Roca-Cusachs A. Potentiation of acenocoumarol motion by L-carnitine. J Intern Med 1993;233:94.

Melegh B, Kerner J, Sandor A, et al. Oral L-carnitine supplementation in low-birth-weight newborns: a research on neonates requiring mixed parenteral and enteral vitamin. Acta Paediatr Hung 1986;27:253-8. View summary.

Memeo A., Loiero M. Thioctic acid and acetyl-L-carnitine within the remedy of sciatic ache attributable to a herniated disc: a randomized, double-blind, comparative research. Clin Drug Investig 2008;28(8):495-500. View summary.

Mezzina C, De Grandis D, Calvani M, et al. Idiopathic facial paralysis: new therapeutic prospects with acetyl-L-carnitine. Int J Clin Pharmacol Res 1992;12:299-304. View summary.

Micic S, Lalic N, Djordjevic D, et al. Double-blind, randomised, placebo-controlled trial on the impact of L-carnitine and L-acetylcarnitine on sperm parameters in males with idiopathic oligoasthenozoospermia. Andrologia 2019;51(6):e13267. doi: 10.1111/and.13267. View summary.

Mingrone G, Greco AV, Capristo E, et al. L-carnitine improves glucose disposal in sort 2 diabetic sufferers. J Am Coll Nutr 1999;18:77-82. View summary.

Mingrone G. Carnitine in sort 2 diabetes. Ann N Y Acad Sci 2004;1033:99-107. View summary.

Mintz M. Carnitine in human immunodeficiency virus sort 1 an infection/acquired immune deficiency syndrome. J Little one Neurol 1995;10:S40-4. View summary.

Miyagawa T, Kawamura H, Obuchi M, Ikesaki A, Ozaki A, Tokunaga Okay, Inoue Y, Honda M. Results of oral L-carnitine administration in narcolepsy sufferers: a randomized, double-blind, cross-over and placebo-controlled trial. PLoS One. 2013;8(1):e53707. View summary.

Moncada ML, Vicari E, Cimino C, et al. Impact of acetylcarnitine remedy in oligoasthenospermic sufferers. Acta Europ Fertil 1992;23:221-4. View summary.

Moretti S, Alesse E, Di Marzio L, et al. Impact of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: a pilot research. Blood 1998;91:3817-24. View summary.

Murakami Okay, Sugimoto T, Woo M, et al. Impact of L-carnitine supplementation on acute valproate intoxication. Epilepsia 1996;37:687-9. View summary.

Naito J, Ohashi H, Ohno M, et al. Lengthy-Time period Levocarnitine Ameliorates Left Ventricular Diastolic as Effectively as Systolic Dysfunction in Hemodialysis Sufferers – Multi-Middle Examine. Circ Rep 2019;1(11):508-516. View summary.

Nebbioso M, Evangelista M, Librando A, Plateroti AM, Pescosolido N. Iatrogenic dry eye illness: an eledoisin/carnitine and osmolyte drops research. Biomed Pharmacother. 2013 Sep;67(7):659-63. View summary.

Neri S, Pistone G, Saraceno B, et al. L-carnitine decreases severity and sort of fatigue induced by interferon-alpha within the remedy of sufferers with hepatitis C. Neuropsychobiology 2003;47:94-7. View summary.

Noble S, Goa KL. Adefovir dipivoxil. Medicine 1999;58:479-87. View summary.

Novak M. Carnitine supplementation in soy-based formula-fed infants. Biol Neonate 1990;58:89-92. View summary.

Nuesch R, Rossetto M, Martina B. Plasma and urine carnitine concentrations in well-trained athletes at relaxation and after train. Affect of L-carnitine consumption. Medicine Exp Clin Res 1999;25:167-71. View summary.

Ohtani Y, Endo F, Matsuda I. Carnitine deficiency and hyperammonemia related to valproic acid remedy. J Pediatr 1982;101:782-5. View summary.

Onofrj M, Fulgente T, Melchionda D, et al. L-acetylcarnitine as a brand new therapeutic strategy for peripheral neuropathies with ache. Int J Clin Pharmacol Res 1995;15:9-15. View summary.

Opala G, Winter S, Vance C, et al. The impact of valproic acid on plasma carnitine ranges. Am J Dis Little one 1991;145:999-1001. View summary.

Passeri M, Cucinotta D, Bonati PA, et al. Acetyl-L-carnitine within the remedy of mildly demented aged sufferers. Int J Clin Pharmacol Res 1990;10:75-9. View summary.

Persico G, Amato B, Aprea G, et al. The early results of intravenous L-propionyl carnitine on ulcerative trophic lesions of the decrease limbs in arteriopathic sufferers: a managed randomized research. Medicine Exp Clin Res 1995;21:187-98. View summary.

Pettegrew JW, Klunk WE, Panchalingam Okay, et al. Medical and neurochemical results of acetyl-L-carnitine in Alzheimer’s illness. Neurobiol Getting old 1995;16:1-4. View summary.

Pistone G, Marino A, Leotta C, et al. Levocarnitine administration in aged topics with speedy muscle fatigue: impact on physique composition, lipid profile and fatigue. Medicine Getting old 2003;20:761-7. View summary.

Plioplys AV, Kasnicka I. L-carnitine as a remedy for Rett syndrome. South Med J 1993;86:1411-2. View summary.

Plioplys AV, Plioplys S. Amantadine and L-carnitine remedy of Continual Fatigue Syndrome. Neuropsychobiology 1997;35:16-23. View summary.

Pons-Rejraji H, Brugnon F, Sion B, Maqdasy S, Gouby G, Pereira B, Marceau G, Gremeau AS, Drevet J, Grizard G, Janny L, Tauveron I. Analysis of torvastatin efficacy and toxicity on spermatozoa, accent glands and gonadal hormones of wholesome males: a pilot potential medical trial. Reprod Biol Endocrinol. 2014 Jul 12;12:65. View summary.

Pooyandjoo M, Nouhi M, Shab-Bidar S, Djafarian Okay, Olyaeemanesh A. The impact of (L-)carnitine on weight reduction in adults: a scientific assessment and meta-analysis of randomized managed trials. Obes Rev. 2016;17(10):970-6. View summary.

Postiglione A, Soricelli A, Cicerano U, et al. Impact of acute administration of L-acetyl carnitine on cerebral blood circulate in sufferers with power cerebral infarct. Pharmacol Res 1991;23:241-6. View summary.

Pourmand G, Movahedin M, Dehghani S, Mehrsai A, Ahmadi A, Pourhosein M, Hoseini M, Ziloochi M, Heidari F, Beladi L, Noori M. Does L-carnitine remedy add any further profit to straightforward inguinal varicocelectomy when it comes to deoxyribonucleic acid injury or sperm high quality issue indices: a randomized research. Urology. 2014 Oct;84(4):821-5. View summary.

Prohaska ES, Muzyk AJ, Rivelli SK. Levocarnitine-induced hypophosphatemia in a hemodialysis affected person with acute valproic acid toxicity. J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):E18-9. View summary.

Rai G, Wright G, Scott L, et al. Double-blind, placebo managed research of acetyl-l-carnitine in sufferers with Alzheimer’s dementia. Curr Med Res Opin 1990;11:638-47. View summary.

Ramos AC, Barrucand L, Elias PR, et al. Carnitine supplementation in diphtheria. Indian Pediatr 1992;29:1501-5. View summary.

Ramos AC, Elias PR, Barrucand L, Da Silva JA. The protecting impact of carnitine in human diphtheric myocarditis. Pediatr Res 1984;18:815-9. View summary.

Raskind JY, El-Chaar GM. The function of carnitine supplementation throughout valproic acid remedy. Ann Pharmacother 2000;34:630-8. View summary.

Rausch CR, Paul S, Marx KR, et al. L-carnitine and Vitamin B Complicated for the Remedy of Pegasparaginase-induced Hyperbilirubinemia. Clin Lymphoma Myeloma Leuk. 2018 Might;18(5):e191-e195. View summary.

Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci 2004;1033:30-41. View summary.

Riva R, Albani F, Gobbi G, et al. Carnitine disposition earlier than and through valproate remedy in sufferers with epilepsy. Epilepsia 1993;34:184-7. View summary.

Rizos I. Three-year survival of sufferers with coronary heart failure attributable to dilated cardiomyopathy and L-carnitine administration. Am Coronary heart J 2000;139:S120-3. View summary.

Rolim LC, da Silva EM, Flumignan RL, Abreu MM, Dib SA. Acetyl-L-carnitine for the remedy of diabetic peripheral neuropathy. Cochrane Database Syst Rev 2019 Jun 15;6:CD011265. doi: 10.1002/14651858.CD011265.pub2. View summary.

Rondanelli M, Opizzi A, Perna S, Faliva M, Solerte SB, Fioravanti M, Klersy C, Edda C, Maddalena P, Luciano S, Paola C, Emanuela C, Claudia S, Donini LM. Acute impact on satiety, resting vitality expenditure, respiratory quotient, glucagon-like peptide-1, free fatty acids, and glycerol following consumption of a mix of bioactive meals substances in obese topics. J Am Coll Nutr. 2013;32(1):41-9. View summary.

Salvioli G, Neri M. L-acetylcarnitine remedy of psychological decline within the aged. Medicine Exp Clin Res 1994;20:169-76. View summary.

Samimi M, Jamilian M, Ebrahimi FA, Rahimi M, Tajbakhsh B, Asemi Z. Oral carnitine supplementation reduces physique weight and insulin resistance in girls with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf) 2016;84(6):851-7. View summary.

Saneian H, Khalilian L, Heidari-Beni M, et al. Impact of l-carnitine supplementation on youngsters and adolescents with nonalcoholic fatty liver illness (NAFLD): a randomized, triple-blind, placebo-controlled medical trial. J Pediatr Endocrinol Metab 2021;34(7):897-904. View summary.

Sangouni AA, Pakravanfar F, Ghadiri-Anari A, Nadjarzadeh A, Fallahzadeh H, Hosseinzadeh M. The impact of L-carnitine supplementation on insulin resistance, intercourse hormone-binding globulin and lipid profile in obese/overweight girls with polycystic ovary syndrome: a randomized medical trial. Eur J Nutr 2022;61(3):1199-1207. View summary.

Sangouni AA, Sasanfar B, Ghadiri-Anari A, Hosseinzadeh M. Impact of l-carnitine supplementation on liver fats content material and cardiometabolic indices in obese/overweight girls with polycystic ovary syndrome: A randomized managed trial. Clin Nutr ESPEN 2021;46:54-59. View summary.

Sano M, Bell Okay, Cote L, et al. Double-blind parallel design pilot research of acetyl levocarnitine in sufferers with Alzheimer’s Illness. Arch Neurol 1992;49:1137-41. View summary.

Sato S, Namisaki T, Furukawa M, et al. Impact of L-carnitine on health-related high quality of life in sufferers with liver cirrhosis. Biomed Rep 2020;13(6):65. View summary.

Sawicka AK, Hartmane D, Lipinska P, Wojtowicz E, Lysiak-Szydlowska W, Olek RA. L-Carnitine supplementation in older girls. A pilot research on getting older skeletal muscle mass and performance. Vitamins 2018;10(2). pii: E255. View summary.

Scaglia F, Longo N. Main and secondary alterations of neonatal carnitine metabolism. Semin Perinatol 1999;23:152-61. View summary.

Scarpini E, Sacilotto G, Baron P, et al. Impact of acetyl-L-carnitine within the remedy of painful peripheral neuropathies in HIV+ sufferers. J Peripher Nerv Syst 1997;2:250-2. View summary.

Schlenzig JS, Charpentier C, Rabier D, et al. L-carnitine: a approach to lower mobile toxicity of ifosfamide? Eur J Pediatr 1995;154:686-7. View summary.

Schmidt-Sommerfeld E, Penn D, Wolf H. Carnitine deficiency in untimely infants receiving whole parenteral vitamin: impact of L-carnitine supplementation. J Pediatr 1983;102:931-5. View summary.

Schmidt-Sommerfeld E, Penn D. Carnitine and whole parenteral vitamin of the neonate. Biol Neonate 1990;58:81-8. View summary.

Schoderbeck M, Auer B, Legenstein E, et al. Being pregnant-related adjustments of carnitine and acylcarnitine concentrations of plasma and erythrocytes. J Perinat Med 1995;23:477-85. View summary.

Schulte RR, Madiwale MV, Flower A, et al. Levocarnitine for asparaginase-induced hepatic damage: a multi-institutional case collection and assessment of the literature. Leuk Lymphoma. 2018 Oct;59(10):2360-2368. View summary.

Sekas G, Paul HS. Hyperammonemia and carnitine deficiency in a affected person receiving sulfadiazine and pyrimethamine. Am J Med 1993;95:112-3. View summary.

Serati AR, Motamedi MR, Emami S, et al. L-carnitine remedy in sufferers with delicate diastolic coronary heart failure is related to enchancment in diastolic operate and signs. Cardiology 2010;116:178-82. View summary.

Serban MC, Sahebkar A, Mikhailidis DP, et al. Influence of L-carnitine on plasma lipoprotein(a) concentrations: A scientific assessment and meta-analysis of randomized managed trials. Sci Rep. 2016;6:19188. View summary.

Shahidi M, Hashemi SR, Fattahi N, et al. The eEffects of L-carnitine on echocardiographic adjustments in sufferers with β-thalassemia main and intermedia. J Pediatr Hematol Oncol. 2020;42(6):386-390. View summary.

Shang R, Solar Z, Li H. Efficient dosing of L-carnitine within the secondary prevention of heart problems: a scientific assessment and meta-analysis. BMC Cardiovasc Disord. 2014 Jul 21;14:88. View summary.

Shapira Y, Gutman A. Muscle carnitine deficiency in sufferers utilizing valproic acid. J Pediatrics 1991;118:646-9. View summary.

Sheida A, Davar R, Tabibnejad N, Eftekhar M. The impact of including L-Carnitine to the GnRH-antagonist protocol on assisted reproductive know-how consequence in girls with polycystic ovarian syndrome: a randomized medical trial. Gynecol Endocrinol 2021;1-5. View summary.

Sherif NA, El-Banna AS, ElBourini MM, Khalil NO. Efficacy of L-carnitine and propranolol within the administration of acute theophylline toxicity. Toxicol Res (Camb). 2020;9(1):45-54. View summary.

Shindo T, Kobayashi Okay, Tanaka T, Masumori N. Can levocarnitine supplementation enhance fatigue attributable to sunitinib as a remedy for renal cell carcinoma? A single-center potential pilot research. Assist Care Most cancers. 2019 Apr;27(4):1491-1496. View summary.

Shingu Y, Katoh N, Ooka T, Katoh H, Wakasa S. L-Carnitine supplementation for the prevention of postoperative atrial fibrillation in aortic valve surgical procedure. Gen Thorac Cardiovasc Surg 2021;69(11):1460-1466. View summary.

Sima AAF, Calvani M, Mehra M, et al. Acetyl-L-carnitine improves ache, nerve regeneration, and vibratory notion in sufferers with power diabetic neuropathy: An evaluation of two randomized, placebo-controlled trials. Diabetes Care 2005;28:89-94. View summary.

Singh RB, Niaz MA, Agarwal P, et al. A randomized, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction. Postgrad Med J 1996;72:45-50. View summary.

Sole MJ, Jeejeebhoy KN. Conditioned dietary necessities and the pathogenesis and remedy of myocardial failure. Curr Opin Clin Nutr Metab Care 2000;3:417-24. View summary.

Spagnoli A, Lucca U, Menasce G, et al. Lengthy-term acetyl-L-carnitine remedy in Alzheimer’s Illness. Neurology 1991;41:1726-32. View summary.

Stanley CA. Carnitine deficiency issues in youngsters. Ann N Y Acad Sci 2004;1033:42-51. View summary.

Stefan M, Sharp M, Gheith R, et al. L-Carnitine Tartrate Supplementation for five Weeks Improves Train Restoration in Males and Girls: A Randomized, Double-Blind, Placebo-Managed Trial. Vitamins 2021;13(10):3432. View summary.

Szymanski M, Wandtke T, Wasilow Okay, Andryszczyk M, Janicki R, Domaracki P. Comparability of 3- and 6-Month Outcomes of Mixed Oral L-Carnitine Fumarate and Acetyl-L-Carnitine Remedy, Included in an Antioxidant Formulation, in Sufferers with Idiopathic Infertility. Am J Mens Well being 2021;15(5):15579883211036790. View summary.

Tabei SM, Mazloom M, Shahriari M, Zareifar S, Azimi A, Hadaegh A, Karimi M. Figuring out and surveying the function of carnitine and folic acid to lower fatigue in ß-thalassemia minor topics. Pediatr Hematol Oncol. 2013 Nov;30(8):742-7. View summary.

Talenezhad N, Mohammadi M, Ramezani-Jolfaie N, Mozaffari-Khosravi H, Salehi-Abargouei A. Results of l-carnitine supplementation on weight reduction and physique composition: A scientific assessment and meta-analysis of 37 randomized managed medical trials with dose-response evaluation. Clin Nutr ESPEN. 2020;37:9-23. View summary.

Tamamogullari N, Silig Y, Icagasioglu S, Atalay A. Carnitine deficiency in diabetes mellitus issues. J Diabetes Issues 1999;13:251-3. View summary.

Tanphaichitr N. In vitro stimulation of human sperm motility by acetylcarnitine. Int J Fertil 1977;22:85-91. View summary.

Tempesta E, Casella L, Pirrongelli C, et al. L-acetylcarnitine in depressed aged topics. A cross-over research vs placebo. Medicine Exp Clin Res 1987;13:417-23. View summary.

Tempesta E, Troncon R, Janiri L, et al. Function of acetyl-L-carnitine within the remedy of cognitive deficit in power alcoholism. Int J Clin Pharmacol Res 1990;10:101-7. View summary.

Thal LJ, Calvani M, Amato A, et al. A 1-year managed trial of acetyl-l-carnitine in early onset AD. Neurol 2000;55:805-10. View summary.

Thal LJ, Carta A, Clarke WR, et al. A 1-year multicenter placebo-controlled research of acetyl-L-carnitine in sufferers with Alzheimer’s Illness. Neurology 1996;47:705-11. View summary.

Thom H, Carter PE, Cole GF, et al. Ammonia and carnitine concentrations in youngsters handled with sodium valproate in contrast with different anticonvulsant medication. Dev Med Little one Neurol 1991;33:795-802. View summary.

Tsoko M, Beauseigneur F, Gresti J, et al. Enhancement of actions relative to fatty acid oxidation within the liver of rats depleted of L-carnitine by D-carnitine and a gamma- butyrobetaine hydroxylase inhibitor. Biochem Pharmacol 1995;49:1403-10. View summary.

Van Wouwe JP. Carnitine deficiency throughout valproic acid remedy. Int J Vitam Nutr Res 1995;65:211-4. View summary.

Vance CK, Vance H, Winter SC, et al. Management of valproate-induced hepatotoxicity with carnitine. Ann Neurol 1989;26:456.

Vecchiet L, Di Lisa F, Pieralisi G, et al. Affect of L-carnitine administration on maximal bodily train. Eur J Appl Physiol Occup Physiol 1990;61:486-90. View summary.

Vermeulen RC, Scholte HR. Exploratory open label, randomized research of acetyl- and propionylcarnitine in power fatigue syndrome. Psychosom Med 2004;66:276-82. View summary.

Vicari E, La Vignera S, Calogero AE. Antioxidant remedy with carnitines is efficient in infertile sufferers with prostatovesiculoepididymitis and elevated seminal leukocyte concentrations after remedy with nonsteroidal anti-inflammatory compounds. Fertil Steril 2002;78:1203-8.. View summary.

Vidal-Casariego A, Burgos-Peláez R, Martínez-Faedo C, Calvo-Gracia F, Valero-Zanuy MÁ, Luengo-Pérez LM, Cuerda-Compés C. Metabolic results of L-carnitine on sort 2 diabetes mellitus: systematic assessment and meta-analysis. Exp Clin Endocrinol Diabetes. 2013 Apr;121(4):234-8. View summary.

Wang DD, Wang TY, Yang Y, He SM, Wang YM. The Results of L-Carnitine, Acetyl-L-Carnitine, and Propionyl-L-Carnitine on Physique Mass in Sort 2 Diabetes Mellitus Sufferers. Entrance Nutr 2021;8:748075. View summary.

Wang Y, Xu Y, Zou R, et al. Impact of Levocarnitine on the Therapeutic Efficacy of Typical Remedy in Youngsters with Dilated Cardiomyopathy: Outcomes of a Randomized Trial in 29 Youngsters. Paediatr Medicine. 2018 Jun;20(3):285-290. View summary.

Wei G, Zhou Z, Cui Y, et al. A Meta-Evaluation of the Efficacy of L-Carnitine/L-Acetyl-Carnitine or N-Acetyl-Cysteine in Males With Idiopathic Asthenozoospermia. Am J Mens Well being 2021;15(2):15579883211011371. View summary.

Weng Y, Zhang S, Huang W, Xie X, Ma Z, Fan Q. Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Evaluation of Randomized Managed Trials. Biomed Res Int 2021;2021:9491615. View summary.

Winter SC, Szabo-Aczel S, Curry CJR, et al. Plasma carnitine deficiency: Medical observations in 51 pediatric sufferers. Am J Dis Little one 1987;141:660-5. View summary.

Wu X, Huang W, Prasad PD, et al. Useful traits and tissue distribution sample of natural cation transporter 2 (OCTN2), an natural cation/carnitine transporter. J Pharmacol Exp Ther 1999;290:1482-92. View summary.

Xu XQ, Jing ZC, Jiang X, et al. [Clinical efficacy of intravenous L-carnitine in patients with right-sided heart failure induced by pulmonary arterial hypertension]. Zhonghua Xin.Xue.Guan.Bing.Za Zhi. 2010;38:152-5. View summary.

Yang SK, Xiao L, Tune PA, Xu X, Liu FY, Solar L. Impact of L-carnitine remedy on sufferers in upkeep hemodialysis: a scientific assessment and meta-analysis. J Nephrol. 2014 Jun;27(3):317-29. View summary.

Yano J, Kaida Y, Maeda T, et al. L-carnitine supplementation vs cycle ergometer train for bodily exercise and muscle standing in hemodialysis sufferers: a randomized medical trial. Ther Apher Dial 2020. On-line forward of print. View summary.

Yarizadh H, Shab-Bidar S, Zamani B, Vanani AN, Baharlooi H, Djafarian Okay. The impact of L-carnitine supplementation on exercise-induced muscle injury: A scientific assessment and meta-analysis of randomized medical trials. J Am Coll Nutr. 2020;39(5):457-468. View summary.

Zelnik N, Fridkis I, Gruener N. Lowered carnitine and antiepileptic medication: trigger relationship or co-existence? Acta Paediatr 1995;84:93-5. View summary.

Zhang JJ, Wu ZB, Cai YJ, Ke B, Huang YJ, Qiu CP, Yang YB, Shi LY, Qin J. L-carnitine ameliorated fasting-induced fatigue, starvation, and metabolic abnormalities in sufferers with metabolic syndrome: a randomized managed research. Nutr J. 2014 Nov 26;13:110. View summary.

Zhang X, Cui Y, Dong L, Solar M, Zhang Y. The efficacy of mixed l-carnitine and l-acetyl carnitine in males with idiopathic oligoasthenoteratozoospermia: A scientific assessment and meta-analysis. Andrologia. 2020;52(2):e13470. View summary.

Zhu Y, Xue C, Ou J, Xie Z, Deng J. Impact of L-carnitine supplementation on renal anemia in sufferers on hemodialysis: a meta-analysis. Int Urol Nephrol 2021;53(10):2149-2158. View summary.